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vSummary
Atherosclerosis and associated cardiovascular diseases are the world’s
biggest cause of mortality. During the acute case of heart attack,
vasodilators are administered to open up the constricted artery and
allow blood perfusion to the surrounding tissue. However, there are
currently no treatments on the market that allow such drugs to be
delivered locally to the site of a critically constricted artery. Such
a targeted delivery method could significantly improve patient prog-
nosis. The presented thesis is an account of the development of a
shear-stress responsive nano-container that could fill this gap in the
medic’s toolbox, using the physical trigger of increased endogenous
shear-stresses in critically constricted human coronary arteries.
In Chapter 2.1, an imaging protocol is presented that sequentially
uses laboratory micro computed tomography (µCT), absorption- and
phase-contrast synchrotron radiation-based µCT (SRµCT) to gather
information on morphology and tissue composition of calcified and
subsequently decalcified coronary arteries. This paves the way for
micrometre-resolution data on the morphology and tissue distribution
of a variety of typical critically constricted vessels.
For flow experiments using shear-stress responsive nano-containers, an
vitro model of the human circulatory system in the healthy and dis-
eased state is developed using plastic model arteries connected to a
heart pump designed for use in heart bypass surgery. The micrometre-
resolution, three dimensional data from human coronary arteries gath-
ered in Chapter 2.1 are invaluable for validating the morphology of
these specifically designed plastic models of healthy and critically con-
stricted arteries. Chapter 2.2 quantitatively compares the morphology
of the plastic model arteries with a critically constricted human coro-
nary artery and a murine model. Using the validated in vitro model
and liposomes formulated from the artificial phospholipid Pad-PC-
Pad, Chapter 2.3 presents the first proof-of-principle that mechano-
sensitive nano-containers could be used in targeted drug delivery.
vi
Lumen meshes extracted from the µCT datasets are required for com-
puter simulations to truly understand the localised shear-stresses at
play in atherosclerotic vessels. Further experiments to construct a
micrometre-resolution shear-stress profile of a typical critically con-
stricted vessel will allow predefined, physiologically relevant “break-
point” shear-stresses to be determined, above which, the nanocontain-
ers should become unstable and release their contents. Such optimised
nano-container formulations could have far reaching implications for
the treatment of cardiovascular diseases and beyond.
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11 Introduction
Cardiovascular diseases are the world’s most prevalent diseases and
number one cause of death [1], responsible for three in ten of all deaths
globally in 2008 [2]. Atherosclerosis is characterised by a narrowing of
the arteries, beginning with formation of fatty streaks on the artery
walls that form lesions in which a lipid core expands, eventually lead-
ing to calcified plaques [3]. When these plaques rupture they partially
or completely block the arteries causing heart attack. Vasodilators
such as nitroglycerine are administered intra-venously to open the oc-
cluded arteries and increase blood perfusion in the surrounding heart
muscle. This improves the patient’s chance of survival and minimises
the damage to the heart caused by ischemic hypoxia. However, the
action of nitroglycerine is systemic and hypotension is a common side
effect. Careful monitoring of the patient’s blood pressure is required
throughout administration and often doses must be adjusted or med-
ication withdrawn altogether to avoid potentially fatal hypotension,
before the desired vasodilatory effect at the heart is achieved. This
problem could be overcome by using nano-container delivery vectors
such as liposomes, to transport such drugs to the heart and release
them preferentially at the site of constriction.
Liposomes in drug delivery
Liposomes are phospholipid bilayers with an internal aqueous com-
partment and are well-established nano-container vectors for targeted
drug delivery, with several formulations currently on the market [4].
Whilst protecting encapsulated contents from chemical and biological
reactions with outer surrounding media, liposomes also pose a hur-
dle for the release of any encapsulated therapeutic agents. Targeted
delivery using liposomes can be achieved by both passive and active
mechanisms. Naked liposomes are rapidly cleared from the body by
the kidneys, however introducing a polyethylene glycol coating cre-
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ates sterically stabilised “stealth” vesicles capable of circulating in the
blood stream for hours or days [5–7]. The classical example of pas-
sive targeting uses the enhanced permeability and retention effect to
target the leaky vascularisation of tumour tissue, whereby these long-
circulating “stealth” liposomes preferentially accumulate around the
tumour periphery over time. The first ever liposome formulation, mar-
keted under the name Doxil in the USA and Cealyx in Europe, used
this principle to improve efficacy and reduce side effects of the drug
doxorubicin in the treatment of ovarian cancer [8–10].
Active targeting typically involves tethering ligands such as antibod-
ies, peptides, folate or transferrin to the liposome surface, which then
bind to specific biomarkers over-expressed in the target pathology
(typically cancers) [4, 10–12]. Cationic liposomes have also attracted
considerable attention as DNA transfection vectors in gene therapies
[13–17]. Unfortunately, there are no reported biomarkers that are
sufficiently specifically over-expressed in critically constricted arter-
ies, which might be used for targeted delivery during myocardial in-
farction. This raises the question of using an alternative targeting
mechanism, such as a physics-based trigger which takes advantage of
the mechano-sensitivity of de novo designed nano-containers to the
increased shear-stresses observed in diseased heart vessels.
Defining the morphology of critically constricted vessels
In order to optimise nano-container formulations with appropriate
mechano-sensitivity to treat advanced cardiovascular disease, one must
first define a) what the exact local wall shear stresses within a criti-
cally constricted vessel are, and how these compare to the common,
healthy situation, and b) what is meant by a critically constricted
vessel in terms of lumen morphology and tissue composition.
There are several computational fluid dynamics-based methods for
calculating wall shear stresses in human coronary artery trees [18].
The arterial morphology on which these calculations are based is of-
ten acquired using in vivo methods such as ultrasound and magnetic
resonance imaging. Pairs of coronary angiograms (measured using
clinical CT) taken at different angles can also be used, and have been
successfully employed in both steady-state and transient flow simu-
lations in healthy coronary arteries [19, 20]. There are a few reports
3of coronary flow simulations in the literature based on stenosed ves-
sels. Rikhtegar and co-workers investigated the suitability of different
wall shear stress parameters for predicting plaque location, based on
coronary angiograph-derived models [21]. Katrisis and co-workers ob-
served blood recirculation in stenoses greater than 90%, along with
a significant flow reduction, the extent of which is governed by the
stenosis’ position in the arterial tree [22]. Using an arterial tree recon-
structed in three dimensions from coronary angiograms, a 50% steno-
sis immediately before or after a bifurcation was also found to lead
to recirculation as well as vortex formation, resulting in a stagnant
flow [23]. However, such data is not available for critically constricted
arteries because there are very few micrometre resolution images of
such vessels, from which meshes can be extracted. Finally, it is also
reported that the vulnerability of a plaque is governed predominantly
by its structure and composition and not the degree of stenosis [24].
Therefore, to identify “culprit lesions” - plaques likely to rupture - it
is essential to understand the local morphology, for example of soft
tissues such as thrombus, collagen, fat and muscle, as well as hard
tissues such as calcifications and the fibrous cap.
It is most common in the literature to report stenosis as the percentage
of vessel occlusion by diameter. Although it is widely accepted that
arteries with over 50% stenosis by diameter present significant steno-
sis and coronary artery disease [25–28], the majority of sites of plaque
rupture are greater than 75% stenosed [29]. Occasionally, percentage
stenosis by both diameter and cross-sectional area are reported simul-
taneously. For example, Virmani and co-workers report vulnerable
plaques with 50% diameter stenosis in over 75% of cases, correspond-
ing to 75% stenosis by cross-sectional area [30]. When these values are
also quantified in absolute as opposed to relative values, the data be-
come even more useful [31], since compensatory vessel wall remodelling
could lead to unrepresentitavely small degrees of percentage stenosis
observed by angiography [25].
Mean diameter stenosis of culprit lesions has been reported as (83.8±
15.8)% [32, 33]. However, there is growing and often conflicting data
concerning the relationship between infarction type and percentage
stenosis of culprit lesions. For example, Huang and co-workers re-
ported a (66.7±23.9)% stenosis for non-ST elevated myocardial infarc-
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tion (NSTEMI) and (78.6±21.2)% for ST-elevated myocardial infarc-
tion (STEMI) culprit lesions measured by 64-slice multi-detector com-
puted tomography (64-slice CT) [34]. Manoharan and co-workers, on
the other hand, used conventional coronary angiography to report an
average diameter stenosis of (68.6±12)% in patients presenting STEMI
versus (71±12)% for NSTEMI, corresponding to a minimal lumen di-
ameter of 0.9±0.4 and 0.7±0.4 mm respectively [35]. Although both
studies claim to have found that a particular infarction type leads to
an increased stenosis in culprit lesions, the errors in both studies are
so large that the only statistically significant conclusion to be drawn
is that both STEMI and NSTEMI lesions occur over a broad and
overlapping range of stenoses. Evidence suggests that the method of
measurement has an effect on the measured constriction, with multi-
slice CT overestimating the percentage diameter stenosis in calcified
plaques (by 11%) but underestimating it in the case of non-calcified
plaques (by 7%), when compared with pathohistology [36]. Although
it provides 3D data, when compared with coronary angiography the
64-slice CT is reported to be an inaccurate tool for predicting the
percentage stenosis [37].
Clearly, the characterisation of “culprit lesions” is non-trivial. Ar-
teries in this thesis are characterised both by percentage stenosis by
cross sectional area (to conform with the literature) and also minimum
cross-sectional area (Chapters 2.1 and 2.2). This second quantity is
more relevant for predicting the required “break points” of mechano-
sensitive formulations for localised drug delivery. Other quantities
commonly seen in the literature, such as percentage stenosis by diam-
eter, can be calculated from the percentage stenosis by cross sectional
area (assuming a circular cross-sectional area).
Micro computed tomography
Visualisation and characterisation of human coronary arteries to diag-
nose and monitor disease progression is an extensively studied area of
medicine [38, 39]. In the clinic, conventional coronary angiography is
the method of choice, with multi-slice CT angiography [40], magnetic
resonance imaging (MRI) [28,41] and echocardiography [42] complet-
ing the clinician’s toolbox. However, these techniques only achieve
resolutions of hundreds of microns and provide limited differentiation
5between tissue types [24, 43]. The gold standard of ex vivo imaging
is histology, which characterises the 2D morphology and tissue com-
position of ex vivo arteries down to the sub-micrometre level, with
the resolution in the third dimension limited only by slice thickness.
However, due to its anisotropic nature, the cutting process leads to
strain and pleat deformations in the 2D data, and since histological
slice preparation is a very lengthy process it is practically unfeasible to
prepare enough consecutive slices to build micrometre-resolution 3D
datasets.
Laboratory micro computed tomography (µCT) in absorption contrast
mode is a convenient, non-destructive technique that provides the re-
quired 3D spatial resolution in the sub-micrometre range. It is ideally
suited to simple cases, for example teeth fixed in formalin where the
attenuation values of the individual components are well-discretised
[44]. In contrast to laboratory µCT, which typically uses cone beam-
emitting X-ray sources, synchrotron radiation-based µCT (SRµCT)
provides such a high photon flux that, using a monochromator, a
monochromatic beam with a reasonable photon flux and improved
spatial coherence and density resolution can be generated [45,46], and
beam hardening is avoided. SRµCT has been used successfully to,
for example, correct for deformations induced during histology [47]
and detect ganglion cells (with the aid of a contrast agent) [48] where
laboratory systems could not.
Both the above methods are examples of absorption-contrast based
imaging, which measures the distribution of local X-ray linear atten-
uation coefficients. For X-rays of given wavelength λ, the complex
refractive index distribution of a specimen can be expressed as
n(x, y, z) = 1− δ(x, y, z) + iβ(x, y, z). (1.1)
While the real part, δ(x,y,z), describes the phase shift (see page 6),
the imaginary part, β(x,y,z), describes the X-ray absorption within the
specimen. This quantity in turn is related to the linear attenuation
coefficient, µ, measured in absorption-based µCT, by
µ(x, y, z) = 4pi
λ
· β(x, y, z). (1.2)
In such a setup, the minimum scan time for a given ratio of sensitivity
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to resolution is given when the equation;
µ ·D = 2 (1.3)
is satisfied, where D the diameter of a homogeneous, cylindrical spec-
imen and µ is inversely proportional to the cube of the optimal pho-
ton energy. Therefore, optimal photon energy is very sensitive to
the specimen’s thickness, density and chemical composition, and it is
impossible to select a single photon energy that provides optimal ra-
diographs of specimens containing both highly X-ray absorbing plaque
and water-dominated soft tissues [49,50].
An alternative to absorption-based µCT is to calculate the phase shift
of the X-rays as they pass through the specimen (based on measureing
the first or second derivitive of the phase shift). Whereas absorption-
based methods measure the imaginary part of the refractive index,
phase contrast-based SRµCT (phase SRµCT) measures the real part,
δ, which is linearly proportional to the inverse of the photon energy.
It is therefore much less dependent on elemental composition of the
specimen, and is the method of choice for imaging samples that con-
tain both soft and hard tissues. Several phase tomography methods
are available today, based on reconstructing the phase shift or decre-
ment of the phase shift [51–56]. This study uses the recently developed
grating-based interferometry, which detects deflection angles of the X-
rays once they pass through the specimen [57, 58]. Since these angles
are in the sub-microradian range, a beam-splitting and analyser grat-
ing are used in a phase-stepping setup to simultaneously yield data on
the phase shift and attenuation values, as in absorption-SRµCT.
Studies using this grating interferometry setup have successfully inves-
tigated the micro-structures of the human cerebellum, visualised indi-
vidual Purkinje cells without the need for a stain or contrast agent [46],
and corrected for deformations incurred during histology [59]. Here,
Chapter 2.1 presents one of the first studies that uses grating-based
phase-SRµCT to visualise human coronary arteries, which unlike hu-
man brain contain a mixture of soft and hard tissues.
Measurements of critically constricted human coronary arteries
The first part of this thesis deals with the development of a protocol
for screening a library of human coronary arteries. Using sequential
7µCT techniques, this protocol enables the user to differentiate between
the plaque, muscle and fat tissues without the use of a contrast agent,
and to determine the 3D morphology down to the micrometre scale
[60].
It is designed to evaluate the morphological characteristics of a stenosed
vessel, with particular reference to the tissue type and microstructure
of the lumen. Phase-SRµCT, in combination with histology, provides
details about the different tissues present, whereas absorption-SRµCT
is more appropriate for lumen segmentation and subsequent flow sim-
ulations due to its smaller pixel size and differing sources of artifacts
between the two measurement modalities [61].
Before any measurements can be made, the specimen must be suitably
prepared. One of the most important steps is the selection of suitable
sections of artery for imaging. This can be done by consulting medical
records of the donor, visual inspection and manually feeling for the
presence of plaques and obstructions. The specimen must then be
extracted, cut to an appropriate size (2 to 3 cm length) and fixed
in formaldehyde. Subsequent embedding in paraffin makes it easier
to transport the specimen and accurately identify areas from the 3D
datasets for histological sectioning, to within fractions of a millimetre.
However, the paraffin embedding process is not without its drawbacks
and can lead to lumen deformation and encapsulation of air bubbles
(particularly problematic for phase-SRµCT where the sharp change in
decrement of the refractive index between air and the paraffin causes
starburst artifacts).
Once five arteries had been appropriately prepared, a Skyscan 1174
setup for bench-top µCT (Skyscan 1174 compact micro-CT, Bruker
microCT, Kontich, Belgium) was used to select three arteries pre-
senting advanced atherosclerosis. Measurement of these arteries in
absorption-SRµCT (Beamline W2, HASYLAB, DESY, Hamburg, Ger-
many) made it possible to additionally visualise the surrounding mus-
cle but not the vessel wall and fatty tissues. This is a problem intrinsic
to the imaging modality, where the optimal X-ray energy is different
for hard and soft tissues. Too low an energy, and the photon statistics
are insufficient due to the highly X-ray absorbing species. Too high an
energy and there is loss in sensitivity for differentiation within the soft
tissues. To better visualise the soft tissues, the most promising artery
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was decalcified to remove the highly X-ray absorbing species, then
re-measured using a lower energy incident X-ray beam and otherwise
identical experimental setup. The lumen morphology could be seg-
mented from this absorption-SRµCT data and was extracted for use
in flow simulations. A region-growing algorithm (Region Growing tool,
VGStudio Max 2.1, Volume Graphics GmbH, Heidelberg, Germany)
was used, since segmentation by thresholding was not possible due
to overlapping attenuation-related values in the intensity distribution,
and the lumen surface was too complex for a feature-based method.
Starting from a selection of seed points, neighbouring voxels within
a fixed intensity range were added to the lumen region of interest
[62]. Flow simulations, conducted in collaboration with PhD-student
F. Rikhtegar of the Kurtcuoglu group at ETH Zurich, calculated wall
shear stresses of over 18 Pa at the site of critical constriction, and less
than 3 Pa elsewhere.
Although the absorption-SRµCT data was ideal for extracting infor-
mation concerning the lumen morphology, it was insufficient for iden-
tification of different soft tissue types. However, it was possible to
distinguish between different tissue types using phase-SRµCT data
(Beamline ID19, ESRF, Grenoble, France) from the same decalcified
artery. Specifically, it was possible to distinguish between muscle,
decalcified plaque and fat using thresholding after visual comparison
with the “gold standard” of 2D analysis, i.e. appropriately stained his-
tological slices. This protocol allows identification of the morphology
and tissue composition of human explanted human coronary arteries
down to the micrometre scale, and could also be applied to other hard
and soft tissue-containing specimens.
A model critically constricted artery
In order to test the suitability of liposome formulations for shear-stress
induced release of a drug, in vitro flow experiments with suitable model
arteries and physiological flow conditions were required [63]. The Swiss
company Elastrat, a supplier of cardiovascular models for training
medical students, was commissioned to design such models for this
purpose, fabricated from polymethylmethacrylate (PMMA). In order
to assess how closely the in vitro results mimic the real, in vivo situa-
tion, it is absolutely essential to quantitatively compare the morpholo-
9gies of the models with real, critically constricted, human coronary ar-
teries. An advanced laboratory µCT setup (Phoenix|x-ray, GE Sens-
ing & Inspection Technologies GmbH, Wunstorf, Germany) was used
in this study to measure a) a PMMA critically constricted and healthy
model artery and b) a decalcified human coronary artery embedded in
paraffin after formalin fixation. Since the attenuation-related values
of the PMMA medium and surrounding air were easily discretised,
a simple histogram-based thresholding method was used to segment
the vessel lumen morphology [64]. The human coronary artery again
required a more complicated region-growing algorithm to extract the
lumen morphology, due to the overlapping attenuation-related values
in the intensity distribution (Region Growing tool, VGStudio Max 2.1,
Volume Graphics GmbH, Heidelberg, Germany).
Additionally, the use of a murine model was also considered. The ex-
planted aorta of an APO E knock-out mouse, bred to present atheroscle-
rosis, was measured using grating-based phase-SRµCT (Beamline BW2,
HASYLAB, DESY, Hamburg, Germany). This imaging method was
selected after an initial unsuccessful attempt to visualise the lumen
with the advanced laboratory µCT set-up, where the attenuation-
related values of the tissue and formalin fixation media overlapped
extensively, leading to incomplete lumen visualisation, and failure to
segment of the lumen morphology. Finally, the total cross-sectional
area and percentage constriction of all three arteries was calculated.
The diseased human artery possessed an (85.2±5)% maximum con-
striction by cross sectional area versus (81.8±5)% in the related PMMA
model. Assuming a circular cross-section, this corresponds to a min-
imum radius of 0.51 and 0.61 mm, respectively. The critically con-
stricted PMMA model had a morphology with similar characteristics
to the studied human coronary artery, and was therefore a valid tool
for identification of nano-container formulations suitable for clinical
studies. It was used for shear-stress induced release studies, published
in Nature Nanotechnology (Chapter 2.3). The mouse aorta however,
unlike in the human coronary arteries studied, presented no significant
constrictions and no calcifications were observed, with only the mus-
cle of the vessel wall distinguishable from the surrounding formalde-
hyde medium. The aorta was smaller than the human coronary artery
measured, with a maximum cross-sectional area of 0.37 mm2 com-
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pared to the human coronary artery maximum cross-sectional area of
5.60 mm2. With a maximum 50% constriction by cross-sectional area,
corresponding to 0.27 mm2 cross-sectional area, the mouse aorta mor-
phology represented a 96% constriction of a 2.5 mm diameter human
coronary artery. However, the constriction in the mouse aorta was due
to the tapering of the artery from the proximal to distal direction and
not any underlying pathology, and unlike a typical diseased human
coronary artery it had a smooth morphology. Finally, the represen-
tative 96% constriction is slightly higher than desired for testing the
suitability of shear-stress sensitive nano-containers.
Shear-stress sensitive liposomes for drug delivery
The final part of this thesis deals with formulating and testing shear-
stress sensitive liposomes using PMMA model arteries with morpholo-
gies corresponding to a critically constricted and healthy coronary
artery. There is sparse literature precedence for such mechano-sensitive
delivery vectors. Almost 20 years ago, Giorgio and Chakravarthy ob-
served that calcium ion permeability of phosphatidylcholine liposomes
was greatly increased when increasing shear stresses within the range
of the mammalian cardiovascular system [65]. Addition of cholesterol,
known to stabilise PC bilayers through hydrocarbon-region interac-
tions, decreased this effect [66]. It was not until ten years later that
the subject resurfaced in a paper by Bernard and co-workers [67],
who found that shear rates in excess of 5,000 s−1 led to an increase
in permeability and fusion in 50 to 400 nm-sized EggPC large unil-
amellar vesicles. Doping with 1 mol% of the surfactant Brij S10 or
increasing the shear rate increased their permeability. However, the
shear stresses and timescales required for appreciable release of encap-
sulated contents were several orders of magnitude higher than those
needed for the in vivo application presented in this thesis. Although
this basic study was far removed from the clinical aim of the current
work, the formulation was taken as a reasonable starting point for
further experiments.
Liposomes with a 100 nm diameter were formulated from EggPC
doped with the surfactant Brij S10 (0-1 mol%), using the well es-
tablished extrusion method reported by Olson and co-workers [68].
They were loaded with an aqueous buffer containing the fluorophore
11
5(6)-carboxy-fluorescein at a self-quenching concentration (50 mM)
[69]. When released from the liposomes, the carboxyfluorescein is di-
luted by the external medium to sufficiently low concentrations that it
is no longer self-quenching and produces a bright fluorescence signal,
the intensity of which is linearly proportional to the extent of release.
The assay thus represents a simple but powerful model to quantify the
release of encapsulated contents from a nano-container.
The formulated liposomes were subjected to in vitro shear stresses un-
der haemodynamic flow conditions using the PMMA models of crit-
ically constricted and healthy coronary arteries. An extracorporeal
circulation pump simulated the heart (Medtronic Bio-Pump, Bio Con-
sole 540, Minneapolis, MN, USA, used in coronary bypass and aortic
valve replacement surgery). The shear stress in each arterial model
was calculated as within reported physiological ranges. The optimal
concentration of Brij S10 for shear-stress induced release was observed
at 0.6 mol%. It led to high differences in fluorescence release between
the healthy and critically constricted PMMA model arteries over long
circulation times. Specifically, 14% more of the total concentration of
encapsulated carbxyfluorescein was released after 40 passes through
the critically constricted than the healthy artery PMMA model. At
Brij S10 concentrations of zero and 1% there was no appreciable dif-
ference in release between the diseased and healthy artery models,
although the 1% Brij S10 formulation was intrinsically less stable on
the bench.
The relation between vesicle shape and stability has historically re-
ceived only minor attention. Lenticular vesicles with large bending
moduli have been computationally predicted to be more susceptible
to mechanical stress than their spherical analogues [70] but this has yet
to be shown experimentally. Thanks to its unusual chemical structure,
the artificial phospholipid Pad-PC-Pad [71] was found to form lentil
shaped vesicles [63]. Unlike natural phospholipids, the hydrophobic
tails are attached to the glycerol backbone using amide linker func-
tionalities. Additionally, the tails are attached in the 1,3 configuration
compared to the 1,2 configuration seen in natural counterparts. This
increases the spacing between the tails, leading to an unfavourably
high-energy state, which is probably stabilised by interdigitation be-
tween the membrane bilayer leaflets. The interdigitation leads to a
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higher Young’s modulus in the bilayer, forcing liposomes to form with
domains of lower curvature and point or edge discontinuities in the
crystal structure, giving lenticular shapes. In comparison with their
EggPC/Brij S10 analogues discussed above, Pad-PC-Pad liposomes
demonstrated a much clearer distinction between release in the heal-
thy and critically constricted artery models; the critically constricted
PMMA artery model led to 25% more release of the total concen-
tration of encapsulated carboxyfluorescein than the healthy PMMA
artery model after only one pass. Finally, liposomes containing mix-
tures of Pad-PC-Pad and EggPC became unstable, or leaky, with an
increase in Pad-PC-Pad concentration, but did not significantly in-
crease their susceptibility to shear-induced release. Indeed, there was
no statistically significant increase in release after one pass through
either the healthy or critically constricted model.
Ideally, a mechano-sensitive nano-container for shear-stress triggered
drug delivery should release 100% of the encapsulated drug on the first
pass through a constricted vessel, but none in the healthy vascular sys-
tem. Although this was impossible with the reported formulation, a
significant preferential release (i.e. 25% increased release after one
pass through an 85% constricted vs. healthy model) could still drasti-
cally improve patient prognosis. Finally, since the publication of these
results, Korin and co-workers [72] reported the use of a different nano-
construct that also utilises the elevated shear-stresses in constricted
arteries for a physics-based, targeted drug delivery. Micrometer-sized
aggregates of poly-lactic-co-glycolic acid were shown to break down
to their individual nano-particle components under shear-stress condi-
tions corresponding to a 60% constricted coronary artery. These nano-
particles were then coated with tissue plasminogen activator (tPA), a
protein involved in breaking down blood clots, and administered in-
travenously to in vivo murine pulmonary embolism models. Here,
they were able to dissolve clots as effectively as a one-hundred-times
more concentrated solution of free tPA. At last, physics-based delivery
vectors are under the radar.
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2 Results
2.1 A systematic protocol using multi-model
micro-computed tomography for uncovering the
morphology and tissue composition of critically
constricted human coronary arteries
A sequential protocol using laboratory then synchrotron radiation-
based µCT in absorption and phase contrast mode resolves the mor-
phology and tissue composition of the soft and hard tissue-containing
human coronary arteries with micrometre precision.
Absorption-SRµCT can be used to extract the lumen morphology for
subsequent flow simulations. Phase-SRµCT, by comparison with his-
tology, can be used to identify different soft tissues. Understanding
the morphology and tissue composition of critically constricted arter-
ies is essential for subsequent flow experiments to test the suitability
of mechano-sensitive nano-containers for targeted drug delivery.
Published in Nature Protocols
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IntroDuctIon
Atherosclerosis is the leading cause of death worldwide1. 
An understanding of the changes in 3D vessel morphology as 
the disease develops provides insights into its relationship with 
blood flow, which is essential for oxygen and nutrient supply 
and waste removal. Specifically, the determination of the generic 
clinical morphology of critically stenosed arteries is a key topic 
of cardiological and vascular research. Flow simulations based 
on high-resolution 3D data sets of real human coronary arteries 
provide in-depth information on physical parameters such as wall 
shear stress in healthy and diseased vessels2. A tenfold increase in 
shear stress is reported in critically stenosed arteries compared 
with their healthy counterparts3. Recently published proof-of-
principle studies are based on using this physical parameter to 
trigger the release of vasodilatory and thrombolytic drugs4,5. The 
precise morphological knowledge of the generic atherosclerotic 
plaque is necessary to determine the shear stresses at calcified 
stenoses in comparison with the healthy arteries in order to tailor 
the targeted drug release.
Advantages and limitations of histology in the analysis of 
heterogeneous tissues
It is widely accepted that histology is the gold standard for tissue 
characterization down to the submicrometer level. In this technique, 
only the wavelength of the applied light limits the spatial resolution 
of the 2D light microscopy images. More importantly, resolution in 
the third dimension, which can be obtained through the prepara-
tion of serial sections, is restricted to tens of micrometers. As the 
diseased arteries contain hard- and soft-tissue components, slicing 
paraffin-embedded arteries is problematic and the resulting slides 
are generally afflicted with preparation artifacts. Such serious arti-
facts change the lumen cross-sectional area6 and render the data 
useless for subsequent blood flow analysis. To optimize the cutting 
strategy, the histologist should know the local arrangement of the 
soft- and hard-tissue components. This knowledge can principally 
be gained from X-ray tomography7, but the tissue inhomogeneity 
gives rise to deficiencies in the tomograms such as streak artifacts, 
which excessively complicate the procedure. As a result, specimens 
containing both soft and hard tissues are difficult to cut and are 
therefore regularly decalcified before slicing. However, the decal-
cification procedure induces heterogeneous strain8 and hence a 
modification of the vessel morphology.
Nondestructive 3D X-ray imaging
Benchtop micro computed tomography (µCT) and synchrotron 
radiation–based micro computed tomography (SRµCT) reach 
true micrometer resolution, although the resolution usually 
remains inferior to that of histology9. SRµCT provides better con-
trast and better contrast-to-noise ratio than benchtop systems10, 
and it has already been used, for example, to correct deforma-
tions induced during histological sectioning11. The absorption 
contrast between different soft tissues is, however, rather weak, 
which makes simultaneous visualization of hard and different 
soft tissues very challenging. To obtain improved soft-tissue 
contrast, SRµCT in phase-contrast mode can be used12,13. X-ray 
phase-contrast methods generate image signal from variations 
of the decrement δ of the X-ray refractive index distribution in 
Complementary X-ray tomography techniques for 
histology-validated 3D imaging of soft and hard 
tissues using plaque-containing blood vessels as 
examples
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a key problem in X-ray computed tomography is choosing photon energies for postmortem specimens containing both  
soft and hard tissues. Increasing X-ray energy reduces image artifacts from highly absorbing hard tissues including plaque,  
but it simultaneously decreases contrast in soft tissues including the endothelium. therefore, identifying the lumen within  
plaque-containing vessels is challenging. Destructive histology, the gold standard for tissue evaluation, reaches submicron 
resolution in two dimensions, whereas slice thickness limits spatial resolution in the third. We present a protocol to  
systematically analyze heterogeneous tissues containing weakly and highly absorbing components in the original wet state, 
postmortem. taking the example of atherosclerotic human coronary arteries, the successively acquired 3D data of benchtop  
and synchrotron radiation–based tomography are validated by histology. the entire protocol requires ~20 working days,  
enables differentiation between plaque, muscle and fat tissues without using contrast agents and permits blood flow  
simulations in vessels with plaque-induced constrictions.
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the specimen (Box 1). A variety of phase-contrast tomography 
methods are available today14–19. Phase-contrast methods that are 
used to retrieve the real part of the refractive index are referred to 
as phase tomography. More recently, phase tomography based on 
X-ray grating interferometry (XGI phase tomography, herein XGI 
phase SRµCT) was developed20,21. This method detects minute 
deflection angles of the incoming X-rays that pass through the 
sample, which are proportional to the first derivative of the phase 
shift. It reaches the particularly high contrast required for identi-
fying structures with tiny differences in electron density22–24.
Overview of the protocol
This protocol enables the user to differentiate between the plaque, 
muscle and fat tissues present within diseased arteries without the 
use of a contrast agent and to determine the 3D morphology down 
to the micrometer scale. By using a combination of nondestructive 
hard X-ray imaging techniques, it allows a detailed analysis of the 
3D morphology of atherosclerosis-presenting human coronary 
arteries, including identification of plaque-containing arteries 
(SkyScan 1174 benchtop µCT), characterization of the lumen 
morphology (absorption SRµCT) and the quantification of the 
amount of the anticipated tissue types such as plaque, muscle and 
fat, and their X-ray phase shifts (XGI phase SRµCT). The results are 
validated by selected subsequently prepared histological slides.
This protocol was designed to evaluate the morphological 
characteristics of a stenosed vessel, with particular reference to 
the tissue type and the microstructure of the lumen. By using a 
SkyScan 1174 setup for benchtop µCT, the most appropriate sten-
osed arteries from all available human specimens was selected for 
absorption and XGI phase SRµCT measurements. Measurements 
using absorption SRµCT allowed us to calculate a maximum of 
75% stenosis by cross-sectional area. This protocol has also been 
used to identify the morphology of a critically stenosed artery 
(>80%; ref. 7). Images obtained using XGI phase SRµCT allowed 
different soft-tissue types to be identified. The data obtained were 
validated by comparison with the gold standard of 2D analysis, 
i.e., appropriately stained histological slides.
Comparing the equipment setup for the CT methods used in 
this protocol
Equipment setup (Fig. 1) for all µCT methods includes the basic 
elements of an X-ray source, a specimen on a high-precision manip-
ulator and a detector. Whereas benchtop µCT uses a polychromatic 
cone beam, the beam in SRµCT is essentially parallel and usually 
monochromatized. As the parallel beam implies that the X-ray image 
is not geometrically magnified before detection, detectors in SRµCT 
setups usually have a smaller pixel size than benchtop methods.
In addition to these basic elements, XGI phase-contrast setups 
include two gratings between the specimen and detector. These 
gratings are used in a phase-stepping regime, in which the beam 
splitter grating (G1) is moved laterally relative to the analyzer 
grating (G2) to quantify minute deflections of the X-ray beam 
due to refraction in the sample (Fig. 2). In benchtop XGI phase-
contrast (not used in this protocol), usually an additional grating 
between the X-ray tube and the sample is needed to fulfill the 
beam coherence requirements.
CT for the determination of tissue composition and morphology
In our recent published work7, we used absorption-contrast 
SRµCT to extract a 3D mesh of tessellated 2D polygons represent-
ing the surface of the artery lumen. Such surface meshes generally 
form the basis for flow simulations to calculate wall shear stresses 
in human coronary arteries25. However, the most important 
factor in the determination of pathogenesis of acute coronary 
Box 1 | Differences in the information extracted from tomography measure-
ments in absorption- (conventional) and phase-contrast modes 
The complex refractive index distribution of an object for X-rays of given wavelength λ is usually written as follows:
n x y z x y z i x y z( , , ) ( , , ) ( , , )= − +1 d b
The X-ray absorption within the object is described by the imaginary part β(x,y,z), which is related to the widely used linear X-ray  
attenuation coefficient µ(x,y,z) by
m p
l
b( , , ) ( , , )x y z x y z= ⋅4
Absorption-contrast CT. The retrieved data in absorption-contrast SRµCT measurements is the distribution of local linear X-ray  
attenuation coefficients for the given X-ray energy.
Phase tomography. In phase-contrast imaging, the signal is generated from the real part of the X-ray refractive index of the  
specimen. As this real part is generally very close to 1, it is usually described by its deviation from unity, the decrement δ.  
Its spatial distribution δ(x,y,z) is directly related to the electron density distribution ρe (x,y,z) of the object by the equation
d l
p
r( , , ) ( , , )x y z r x y ze e=
2
2
 
with the classical electron radius re (ref. 68). Most of the phase-tomography measurements are, however, based on the first  
or second derivative of the phase shift and thus require procedures to calculate the local decrements of the refractive index  
(phase retrieval).
2.1 A systematic protocol using multi-model micro-computed tomography for
uncovering the morphology and tissue composition of critically constricted human
coronary arteries 15
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syndromes is the structure and composition of the atherosclerotic 
plaques, rather than the extent of stenosis26. The likelihood of a 
plaque rupturing (its vulnerability) depends on its tissue struc-
ture. To understand the vulnerability of a plaque, it is essential 
to understand the local morphology, for example, of soft tissues 
such as thrombus, collagen, fat and muscle, as well as hard tissues 
such as calcifications and the fibrous cap. It is often impossible 
to image the individual tissue types within an ex vivo coronary 
artery by using benchtop µCT, which only allows differentiation 
between three tissue types, i.e., calcified atherosclerotic plaques, 
fat tissue and mixed tissue.
In clinical imaging, multidetector-row computed tomogra-
phy (MDCT) with barium sulfate contrast agent has been used 
to attempt to differentiate calcified and noncalcified plaques26. 
Artifacts can occur owing to extreme calcifications or incomplete 
filling of arteries with contrast medium. Other methods are avail-
able, such as dual-source CT scanners, which permit simultaneous 
scanning at two peak X-ray energies. The combination of images 
obtained at two acceleration voltages allows marked improvement 
in the identification of anatomical structures compared with con-
ventional lab-based CT27.
For imaging tissues with prominently varying degrees of miner-
alization, XGI phase tomography is becoming an indispensable tool 
because of its combination of high soft-tissue contrast with micro-
scopic resolution in full 3D28. As with other CT techniques, subse-
quent correlation with histology is possible and can help interpret 
the tomography images. In this protocol, we use XGI phase tomog-
raphy on a synchrotron radiation source. This technique has been 
demonstrated to be compatible with conventional X-ray sources29, 
and recently results from a preclinical scanner based on this principle 
were reported30.
Our group has used both XGI phase SRµCT and absorption-
based µCT to visualize a variety of anatomical structures7,22,28,31–34. 
Herzen et al.35 showed that XGI phase SRµCT can be used to 
visualize the microstructure of urethra, 
in which absorption-contrast SRµCT was 
not sensitive enough to detect differences 
between the absorption values within the 
tissues and the surrounding fluid (formal-
dehyde). In 2010, XGI phase and conven-
tional absorption SRµCT setups similar to 
the ones reported here were used to inves-
tigate the microstructures of the human 
cerebellum, and to visualize individual 
Purkinje cells without the need for a stain 
or contrast agent22.
Multimodal data registration
Techniques to register data sets can be 
broadly broken down into two approaches, 
namely intensity- and feature-based algo-
rithms. The inherent dimensionality 
reduction ability of feature-based techniques makes them suit-
able for large data sets. However, matching features between data 
sets obtained from different imaging modalities is frequently 
nontrivial, and in these cases intensity-based registration that 
relies on the classical maximization of mutual information is 
often more suitable36,37. Affine and nonrigid registration algo-
rithms can, for example, provide information on the effects of 
global volume change and local strain field of the human brain 
during extraction and formalin fixation of the whole brain, 
by using data sets that are acquired via MRI38. These registra-
tion methods can, in some cases, also be used to compare 3D 
SRµCT images with 2D histological slices11,39. In particular, 
these registrations facilitate the correction of artifacts such as the 
formation of pleats during the preparation of histological slides. 
Indeed, further studies found that XGI phase SRµCT followed 
by histological slide preparation could lead to improvements 
in the accuracy of stereotactic brain atlases used for noninva-
sive MR-guided neurosurgery32. Similarly, 3D µCT data sets 
have been used to select appropriate representative histological 
slices for the analysis of bone augmentation materials in human 
mandibles. Subsequent registration of the 3D µCT data sets 
with 2D histological slices allowed 2D histograms to be plotted, 
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Figure 1 | Schematics of setups for µCT imaging.
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Figure 2 | XGI phase SRµCT setup at ESRF. From left to right, along the 
incident X-ray beam; sample holder, phase grating (beam-splitter grating, 
G1; periodicity, P1), absorption grating (analyzer grating, G2; periodicity, 
P2) and detector. The distance d between G1 and G2 is chosen for optimum 
tradeoff between contrast and resolution. The reconstructed value is the 
difference (∆δ) between the real part of the refractive index in the sample 
(δ) and surrounding water bath (δwater)22.
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which were used to identify anatomical features that cannot be 
identified by histology or µCT alone39.
The protocol presented here has been used to extract infor-
mation from multimodal imaging techniques about both the 
morphology and tissue composition of atherosclerotic human 
coronary arteries7, which, unlike human brain and teeth, contain 
a mixture of soft and hard tissues.
Determination of the lumen of the diseased vessels
To determine the actual lumen of vessels (i.e., shape and cross- 
section), staining agents such as iodine compounds and barium 
sulfate emulsions have been successfully applied40–43. The reliable 
application of such staining agents for human tissues, especially for 
the smallest capillaries, however, has not yet been demonstrated. 
In addition, the pressure applied to fill the vessels with staining 
agent can deform the inhomogeneous, diseased walls or even lead to 
unintentional leakage of the medium. Therefore, such an additional 
preparation step should be avoided whenever possible.
Pai et al.44 have shown that osmium tetroxide (OsO4) as a stain-
ing agent to image artery walls of mice is reasonable even when 
applying conventional X-ray sources. This approach has excellent 
potential, as the agent binds to the lipids that are responsible for 
the plaque formation, so that even early stages of plaque forma-
tion are assessable. Unfortunately, the spatial resolution of both 
the conventional and the synchrotron radiation–based setups was 
~10 µm, which is more than one order of magnitude larger than 
the wall thickness of capillaries in mice and only slightly smaller 
than the ~50-µm wall thickness of the largest arteries. As a result, 
only very few vessels with a restricted number of bifurcations were 
identified. Therefore, the 3D images had restricted quality, and 
any quantification of the morphology of stenosed arteries via this 
approach, such as changes in the cross-section along the individual 
vessel, has to be regarded as questionable. Furthermore, OsO4 is 
highly toxic and, if possible, it is preferable to avoid handling this 
and other toxic compounds. Finally, it is unclear to what extent 
the application of OsO4 gives rise to local deformations caused by 
nonhomogeneous shrinkage of the soft tissues, which can mark-
edly influence the quantification of the lumen morphology.
Segmentation of morphological features
In this protocol, the lumen morphology is segmented from the 
absorption SRµCT data set and extracted for use in flow simula-
tions. In biomedical image segmentation, histogram-based meth-
ods are very efficient when the intensity distribution allows the 
choice of appropriate thresholds45. When the intensities of the 
local absorption values overlap substantially, more sophisticated 
approaches are required, such as feature-based and region-growing 
algorithms. Feature-based approaches detect objects by their 
characteristic structure; for example, the Frangi filter identifies 
vessels by their tubular structure46. A region-growing algorithm 
adds neighboring voxels within a range of intensity to an object 
starting from a selection of seed points47. In this study, the arteries 
are segmented well by using region growing, whereas thresholding 
leads to insufficient results and the lumen surface is too complex 
for a feature-based method.
Experimental design
Specimen preparation. Before the tomography measurements, the 
specimens must be appropriately prepared. This involves extracting 
up to the entire coronary artery tree from a donated heart, care-
fully selecting a suitable section of coronary artery, removing 
surrounding tissue, fixing the specimen in formaldehyde, and 
subsequently selecting appropriate embedding material (paraffin, 
formaldehyde or polymer resins) and containers for storage and 
measurement. In addition to calcified, diseased arteries, healthy 
specimens may also be selected for comparison. Further prepara-
tory steps are required if the sample needs to be decalcified, e.g., 
for the histological sectioning. The decalcification process dis-
solves hard-tissue components, which in this case is plaque; this 
is an essential step before cutting histology slices. Decalcification 
is also often beneficial for the µCT imaging. It allows the use of 
lower photon energies, and it therefore provides increased contrast 
between soft-tissue components at the cost of losing information 
about the hard tissues dissolved during the process.
Preparation for beamline measurements. Once the specimen 
is prepared, it must be transported to the beamline. This often 
involves the crossing of international borders, which requires nec-
essary legal paperwork with related administrative procedures 
and delays. For the tomography measurements, the samples are 
usually glued to a sample holder and fixed on a high-precision 
manipulator. These preparatory steps are extremely important, 
and they must not be overlooked. Inappropriate specimen prepa-
ration can lead to severely decreased image quality.
Data acquisition. The necessary beamtime correlates with the selected 
photon energy. In conventional, absorption-based µCT, the minimum 
scan time for a given ratio of sensitivity to resolution is given when 
the equation m ⋅ =D 2 is satisfied, where µ is the linear X-ray attenu-
ation coefficient (Box 1) and D is the specimen diameter48. Between 
absorption edges, µ is inversely proportional to the cube of the photon 
energy. The optimal photon energy therefore varies with thickness, 
density and chemical composition of the sample. For example, by 
assuming a cylinder that is 1 cm in diameter, the above equation is 
satisfied when µ = 2 cm−1, which occurs at 14 keV for a water-only 
specimen, but 100 keV for an iron-only specimen. Therefore, it is 
impossible to select a single photon energy that provides optimal 
radiographs of specimens containing highly X-ray-absorbing plaque 
and water-dominated soft tissues48,49.
Phase tomography yields the real part of the refractive index 
relative to the surrounding medium (∆δ) (Box 1). This part of the 
refractive index is linearly proportional to the inverse of the photon 
energy. It is also much less dependent on the elemental composition 
of the specimen than the imaginary part. As a consequence, phase 
tomography is much more suitable for differentiating between dif-
ferent soft tissues in the presence of hard tissues.
The image quality is a function of the exposure time. The 
detector normally has a 12–14-bit (i.e., 4,000:1–16,000:1) 
dynamic range—i.e., a ratio of maximum signal to noise. The 
initial exposure time is set before the recording of the radio-
graphs starts. To ensure an optimized photon density in each 
radiograph, algorithms compensate for temporal modulations 
in the X-ray beam. To maximize the contrast between soft- 
tissue components, it is preferable to use the full dynamic range 
of the detector.
The quality of the tomography data depends on the number 
of acquired projections. The 3D data are reconstructed from a 
series of radiographs, which today are usually ~1,000, taken at 
2.1 A systematic protocol using multi-model micro-computed tomography for
uncovering the morphology and tissue composition of critically constricted human
coronary arteries 17
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fixed incremental angles of rotation. The number of projections 
for best resolution of a specimen with diameter D is intrinsically 
linked to the number of detector pixels along D. Assuming a 
symmetrical rotation center, the displacement between the cor-
responding image features in neighboring radiographs is dictated 
by the angular increment and maximal distance from the rotation 
center. Sampling theory stipulates that the number of required 
radiographs for a symmetrical rotation center is nr × π/2, where nr 
is the number of pixels along the maximal diameter of the speci-
men. The data at the edge of the specimen are furthest from the 
rotation center, and thus they have the greatest displacement. To 
ensure maximal spatial resolution, the distance between points in 
consecutive radiographs must be smaller than the effective pixel 
size of the detector, but it should be large enough to minimize the 
scan time. The spatial resolution within the radiographs is often 
a factor of 1.5–2.0 poorer than the limit given by the pixel size. 
Thus, one records fewer radiographs without compromising the 
image quality in the tomograms. An optimized angular increment 
between individual radiographs, i.e., a reasonable compromise 
between spatial resolution and scan time, should be determined 
before the measurement starts. During data acquisition, in addi-
tion to the projection radiographs of the specimen, images need 
to be taken with the sample removed from the beam, termed flat-
field images, against which the radiographs are normalized to 
correct for the inhomogeneity in the beam profile. The proce-
dure is usually automated. For long scan times as in this protocol, 
flat-field images are required at periodic intervals throughout the 
measurement to correct for time-dependent fluctuations in the 
beam profile.
Adapting the protocol to other specimen types. The protocol can 
be adapted to measure any explanted human or animal specimen 
containing both soft and hard tissues, including specimens from 
the diseased heart, vascular system, amyloid plaque–containing 
brain or articulations (see, for example, ref. 28). X-ray energy 
should be carefully chosen for the tissue type. In biological 
specimens with a diameter of ~1 cm, soft tissues are typically 
resolved with a photon energy of 10–20 keV and calcified tissues 
are resolved with a photon energy of 25–50 keV. Selecting too low 
an energy leads to insufficient photon statistics caused by highly 
X-ray-absorbing species, whereas too high an energy leads to loss 
in sensitivity for differentiation within the soft tissues. In addition, 
the photon energy for XGI phase SRµCT must match the design 
energy of the available grating setups. The main limiting factor 
in the measurements is often the specimen size. Stitching tech-
niques (e.g., asymmetric rotation axis with respect to the incom-
ing beam34) can increase the horizontal field of view. Stitching 
multiple height steps together can increase the vertical field of 
view50. The time to scan each height step is in the region of 2–6 h 
for optimally high-density-resolution SRµCT measurements, 
depending on the protocol, so the amount of beamtime available 
limits the number and size of specimens that can be measured. 
We recommend that the technique be used only for measuring 
specimens up to a diameter of slightly less than twice the available 
maximum width of the radiographs. For the beamline ID19 at the 
European Synchrotron Radiation Facility (ESRF), this means a 
maximum sample diameter of ~9 cm. The height of the investi-
gated sample region, insofar as it exceeds the height of the field of 
view, will depend on the amount of beamtime available.
MaterIals
REAGENTS
 crItIcal In our work, all solvents were purchased from Merck,  
Ultraclear or JTBaker, and they were used as supplied.
Tissue samples
The starting material for this procedure is human coronary arteries.  
In our published work7, 2.5-cm-long arteries were selected for analysis  
from the Institute of Forensic Medicine, University Medical Center,  
Hamburg-Eppendorf, Germany, in consultation with medical doctors  
(specialists in pathology, internal medicine and critical care). The  
selection criteria were as follows: visual evidence of atherosclerosis;  
palpating of substantial amounts of hard tissue in the artery; and evidence 
of infarction zone on the myocardium ! cautIon Samples should be  
removed in accordance with the ethical regulations and guidelines of the  
investigator’s institution and, if applicable, with the consent of the  
patient and the patient’s family. In this case, specimens were collected  
postmortem from individuals who donated their bodies for teaching  
and research purposes to the Institute of Anatomy, University of Basel,  
Switzerland.  crItIcal Careful selection of the artery is paramount for 
generic results. Medical records were unavailable here, but they would be 
another useful tool for selecting typical stenosed arteries.
Tissue preparation
Fixation material: buffered formaldehyde, 4% (vol/vol) in water
Decalcification materials: formic acid, formaldehyde, ammonium  
oxalate, ammonia solution, distilled water
Dehydration materials: xylene, alcohol, paraffin
Histological stains: hematoxylin and eosin (H&E),  
Masson’s Trichrome, Miller
EQUIPMENT
For artery preparation
A scalpel is required for removing the surrounding tissue, and paraffin 
(after the embedding process)
•
•
•
•
•
•
Dehydration: Tissue-Tek VIP E300 Histokinette automated dehydrator 
(Sakura)
Histological slices: Microm Cool-cut HYRAX M 40 (Carl Zeiss)
For data collection
XGI phase SRµCT setup, beamline ID19, ESRF28,51
Absorption SRµCT setup, beamline BW2, Helmholtz-Zentrum Geesthacht 
(HZG) Research Centre, HASYLAB, Deutsches Elektronen-Synchrotron 
(DESY)52. The software IDL 8.1 (Exelis Visual Information Solutions) was 
used for data collection and preprocessing
Benchtop µCT setup (SkyScan 1174 compact micro-CT, Bruker microCT)
Nikon Eclipse 80i microscope (Nikon) for photography of histology slides
Software for data reconstruction
Benchtop µCT, NRecon (Bruker microCT)
Absorption SRµCT, standard filtered back-projection algorithm at the 
beamline52, by using an implementation of the RECLBL Library53
XGI phase SRµCT, code written in-house using MATLAB R2010b  
(MathWorks)54. Note that more powerful resources are available at  
the synchrotron beamline. These could also have been used for  
data reconstruction
Programs for data visualization and analysis
Absorption SRµCT and XGI phase SRµCT: VGStudio Max 2.1  
(Volume Graphics) and MATLAB R2010b
H&E-stained histology slides: Fiji, ImageJ, version 1.45k (EMBL) and  
Adobe Photoshop CS3 (Adobe)
Benchtop µCT: VGStudio Max 2.1
Preprocessing for flow simulations: Geomagic Studio 12 (Geomagic)  
and ANSYS ICEM CFD (ANSYS)
Flow simulations: ANSYS CFX (ANSYS)
EQUIPMENT SETUP
Benchtop mCT For preliminary benchtop µCT scans, use a SkyScan 1174 
or a similar model. Note that this µCT system is among the most basic of its 
•
•
•
•
•
•
•
•
•
•
•
•
•
•
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kind, allowing for very simple operation with minimal user training.  
Select an appropriate acceleration voltage and beam current for each  
specimen. Initial values should be chosen by reference to the literature 
and/or on the basis of previous experience. The Experimental design section 
‘Adapting the protocol to other specimen types’ contains guidelines for the 
selection of the specific values. These initial values can be fine-tuned after 
performing preliminary scans. In our case, we used an acceleration voltage  
of 35 kVp and an 800-µA beam current. Figure 3 shows characteristic  
examples of plaque present in human coronary arteries, which are measured 
using these parameters. See Table 1 for details of experimental parameters for 
this and subsequent µCT steps. Comparisons of the µCT equipment  
and methods can be found in Table 2 and Box 2.
Absorption SRmCT for nondecalcified artery  Monochromatize the  
X-ray beam, select an appropriate photon energy, and insert and center  
the sample on the sample manipulator. The rotation axis of the specimen 
should be aligned to the pixel rows of the detector to allow the parallel  
reconstruction of tomography slices. The manipulator not only allows  
for precise sample rotation but also for sample translation to record  
the intensity distribution within the X-ray beam without specimen for 
normalization. To improve photon statistics, and thus density resolution, 
combine pixels in the projection radiographs by, for example, a binning  
factor of two in each dimension49.
In our case, the highly intense, collimated X-ray beam at the beamline 
BW2 (HASYLAB, DESY) is monochromatized by means of a fixed-exit 
double-crystal monochromator (Si(111)-crystals) to the photon energy of 
23 keV with a relative bandwidth of 10−4. The tomography setup, installed 
40 m from the radiation source, consists of the sample manipulator and the 
charge-coupled device (CCD)-based area detector. The X-ray image detector 
consists of a luminescent screen (270-µm-thick CdWO4 single crystal), an 
optical lens (Nikkor 35 mm focal length, Nikon) and the CCD camera (KX2, 
Apogee Instruments, 14-bit digitization at 1.25 MHz, 1,536 × 1,024 pixels, 
each 9 µm × 9 µm). The luminescent screen converts the incident X-rays 
into visible light, projected with the magnification of 3.05 onto a CCD chip, 
resulting in an effective pixel size of 2.95 µm. See Figure 4 for characteristic 
examples of calcified human coronary arteries measured by using this setup.
Absorption SRmCT for decalcified artery Follow the procedure described 
above, with lower photon energy (in our case, 14 keV).
XGI phase SRmCT for decalcified artery  Monochromatize the beam,  
select an appropriate photon energy, and insert and center the sample in the 
water tank (Fig. 2). During phase-contrast measurements, immerse the speci-
men in a water tank with parallel walls (we use Kapton plates). This arrange-
ment minimizes artifacts due to strong phase shift at the interface between 
air and the paraffin-embedding material. In our setup, the specimen and tank 
are located ~10 cm upstream of the beam-splitter grating, which has a  
periodicity of p1 = 4.785 µm and a Si structure height of 29 µm. The  
photon energy of 23 keV was selected using a double-crystal Si(111)  
monochromator. With a distance between source and interferometer of  
150 m and a distance between the gratings of d = 481 mm (9th Talbot order), 
the ratio of the grating periods, p2/p1, is matched to the beam divergence55. 
The detector, placed ~3 cm downstream of the analyzer grating with gold 
lines of a periodicity of p2 = 2.400 µm and a structure height of 50 µm, is a 
lens-coupled scintillator and CCD system that uses a FReLoN (Fast-Readout, 
Low-Noise, ESRF, Grenoble, France) CCD with 2,048 × 2,048 pixels.  
The effective pixel size corresponds to 5.4 µm.
a b c dFigure 3 | 3D representations of four characteristic plaque morphologies 
with different degrees of stenosis obtained from SkyScan 1174 compact 
micro-CT. (a–d) Shown are: concave plaque (a,b), circumferential plaque 
(bottom of c,d). The length of each artery specimen is ~2.5 cm.
table 1 |  Parameters for image acquisition in PROCEDURE Steps 2, 3, 5 and 6.
non-decalcified artery Decalcified artery
benchtop mct absorption srmct absorption srmct XGI phase srmct
Protocol step number 2 3 5 6
Photon energy ≤35 keV  
(800 µA beam current)
24 keV 14 keV 23 keV
Number of radiographs 1,200 1,440 1,440 999
Rotation angle increment 360°/1,200 360°/1,440 360°/1,440 360°/999
Rotation axis position Centered Asymmetric Asymmetric Centered
Projection size (pixels) 1,024 × 1,024  1,536 × 751 1,536 × 1,023 2,048 × 2,048
Pixel length (µm) 14.4 7.2 or 7.9 5.3 5.4
Scan time per height step 60 min 220 min 220 min 390 min
Number of height steps 2 4 or 2 2 2
Total size of raw data 5 GB (16 bit) 15 GB for 4  
height steps (16 bit)
10 GB (16 bit) 67 GB (16 bit)
Size of reconstructed data 0.2 × 1010 voxels  
(2 GB, 8 bit)
5.4 × 1010 for 4 height  
steps (50 GB, 8 bit)
1.8 × 1010  
(17 GB, 8 bit)
1.7 × 1010  
(32 GB, 16 bit)
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Computing equipment for benchtop mCT Data acquisition:  
Dell Precision 490 workstation with a four-core 2.66-GHz Intel Xeon  
processor, 4 GB of RAM, a 256-MB ATI FIRE GL V7200 (MRGA13B)  
graphics card and Windows XP Professional. Data reconstruction:  
Dell Precision 490 workstation with a four-core 2.66-GHz Intel Xeon  
processor and 8 GB of RAM with 64-bit Windows 7 Enterprise.
Computing equipment for absorption SRmCT Data acquisition: Pentium 
DualCore CPU 3.4 GHz, 4 GB RAM running Windows XP Professional.  
Data reconstruction: several workstations running Scientific Linux, with a 
total of 128 GB of RAM and 48 cores.
Computing equipment for XGI phase SRmCT Data acquisition:  
PC cluster available at the beamline. Data reconstruction: Dell Precision 
T5500 workstation with a 64-bit Linux openSUSE 11.3 operating system  
with a total 24 GB of RAM and four cores. This setup was also used for  
registering the absorption and XGI phase SRµCT data sets. This was the  
computing equipment at the university laboratory; it should be noted that 
more powerful resources are available at the synchrotron beamline, and  
they could have been used for reconstruction of the data.
Computing equipment for flow simulations Image data preprocessing, 
steady-flow calculations and postprocessing of results; Fujitsu Celsius R670-2 
1 mm
Figure 4 | Absorption SRµCT visualization of plaque and cardiac muscle. 
Top, 3D visualization of plaques of three nondecalcified human coronary 
arteries, corresponding to Figure 3a–c, extracted by using intensity-based 
thresholding45. White arrows denote the location of slice (below) within the 
plaque. Bottom, 2D slices showing plaque (white) and muscle (dark gray). 
proceDure
 crItIcal The experiment can be paused after any step, for example, while waiting for an available beamtime, provided 
that the artery is stored appropriately (i.e., fixed in formaldehyde and embedded in paraffin). The chronology is presented 
below. The order of the absorption and XGI phase SRµCT steps can be swapped. Details of the parameters used in the image 
measurements are given in table 1. table 2 highlights the differences in tissue visualization, experimental time and cost 
(box 2) and complexity of each µCT method.
artery extraction, fixation and embedding ● tIMInG 48 h per artery
1| Extract the artery as soon as possible after death and select an appropriate specimen (see ‘Tissue samples’ in Reagents). 
For vessel specimens 2–3 cm long, fix them in at least 20 times the sample volume of 4% (vol/vol) formaldehyde for at least 
10 h, to ensure that fixation is complete. This step may take up to 2 d for large specimens with plenty of plaque. Marking 
the orientation of the specimen will help with data registration.
2| Dehydrate the artery by soaking it under reduced pressure overnight in alcohol, followed by xylene, and then immerse  
it in molten paraffin at a temperature of 60 °C.
3| Embed the artery in a paraffin block. Once it is cooled, minimize the specimen diameter by, e.g., trimming it with a 
scalpel, to be able to use pixel sizes as small as possible while imaging the whole object.
 crItIcal step Embedding in paraffin after fixation in formaldehyde is advisable for measurements, as it prevents  
movement of the sample during the experiment and allows the same region to be easily identified for imaging and analysis. 
Take care to ensure that there are no trapped air bubbles in the paraffin, particularly inside the vessel. Such air bubbles,  
even microscopic ones, lead to strong artifacts in the XGI phase SRµCT images.
Measurement 
4| The nondecalcified sample can now be analyzed by benchtop µCT (option A, SkyScan 1174 benchtop micro-CT)  
and/or by SRµCT (option B).
(a) benchtop mct ● tIMInG 75 min per height step plus data reconstruction time
 (i)  To minimize the pixel size, set the geometric magnification to a value that allows the entire specimen to just fit into  
the field of view for all radiographs. In our case, this resulted in a pixel size of 14.4 µm2 (table 1).
workstation with a six-core 2.53-GHz Intel Xeon processor E5649 and 48 GB 
of RAM with 64-bit Windows 7 Professional. Transient flow simulation is 
conducted using 16 parallel nodes of Brutus, the central high-performance 
cluster of ETH Zurich, Switzerland.
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table 2 | Comparison of µCT methods
specimen plaque-containing artery artery with plaque removed
Measurement type benchtop mct absorption srmct absorption srmct XGI phase srmct
Visualization
Hard tissues  
 (calcified plaque)
Local intensity–based 
segmentation
Local intensity–based seg-
mentation, streak artifacts
Traces of plaque  
observable, plaque-
related artifacts
Traces of plaque observable,  
no plaque-related artifacts
Lumen segmentation Invisible Invisible Segmented using  
region-growing tools
Partially segmentable, artifacts 
from embedded air bubbles
Identifiable soft  
 tissues  
 (correspondence  
 to histology)
None Surrounding heart muscle Muscle, fibrous cap,  
cholesterol, adventitia 
and foamy cells (no  
distinction); residual 
plaque
Foamy cells, cholesterol,  
epithelium and adventitia  
(no distinction); muscle and 
fibrose cap (no distinction); 
residual plaque
Experiment time for one height step
Experiment setup 0.25 h, center sample, 
select experimental 
parameters
5 h, beamline  
setup; 0.5 h, select param-
eter settings
5 h, beamline setup;  
0.5 h, select parameter 
settings
5 h, beamline setup; plus  
extra 5 h, grating setup;  
0.5 h, select parameter settings
Measurement 1.2 h 3.7 h 3.7 h 6.5 h
Preparative work for  
 reconstruction
None 1.5 h 1.5 h 3 h (image processing)
Reconstruction  
 using the described 
 computing  
 equipment  
 (see ‘Computing  
 Equipment’)
1 h 0.5 h 0.5 h 4.5 h
Cost and complexity
Cost of equipment $100,000 to purchase 
plus $5,000 running 
costs per year
Beamtime free of charge 
if beamtime granted 
through peer-review  
process (box 2)
Beamtime free of charge 
if beamtime granted 
through peer-review  
process (box 2)
Beamtime free of charge if 
beamtime granted through 
peer-review process (box 2), 
including XGI phase SRµCT 
setup (Figure 2)
Complexity of  
 equipment setup
Introduction required, 
can be done by under-
graduates
Can be operated by non-
expert scientist or graduate 
student after basic training
Can be operated by 
non-expert scientist or 
graduate student after 
basic training
Requires assistance from experts
 (ii)  Reconstruct the data by using the manufacturer’s NRecon software (based on a modified Feldkamp algorithm) with  
a correction to reduce ring and beam-hardening artifacts within the tomography data set. Suitable parameters for 
beam-hardening compensation should be defined in an iterative process. The number of iterations required to reach 
optimum parameters can be greatly reduced by consulting suppliers and experts in the field. 
? troublesHootInG
(b) srmct for nondecalcified artery ● tIMInG 3 h 40 min per height step plus data reconstruction time
 (i)  At a beamline with SRµCT setup optimized for absorption contrast mode, acquire ~1,000 radiographs at equiangular 
steps along 180°. If necessary, use an asymmetric rotation axis with respect to the detector center, record radiographs 
at equiangular steps along 360° and combine the opposite radiographs to create radiographs with up to two times 
more pixels for the spatial resolution increase (table 1)50.
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 (ii)  Experimentally characterize the spatial resolution of the setup by using the 10% value of the modulation transfer  
function from a highly X-ray–absorbing edge31. In our case, the derived values corresponded to 7.24 and 7.88 µm, 
respectively. Although the X-rays from synchrotron radiation sources are not completely parallel, they are sufficiently 
parallel that the tomograms can be reconstructed slice-wise by using a standard filtered back-projection algorithm  
for a parallel beam. 
? troublesHootInG
artery decalcification and re-embedding in paraffin ● tIMInG 3 d in total
5| Preparation of the decalcifier. This is a solution of distilled water:formic acid:formaldehyde (87:8:5 (vol/vol)).
! cautIon Decalcification solvents are corrosive and carcinogenic. Handle them in a fume hood with gloves.
6| Remove paraffin from the artery by heating it to 60 °C, and then wash the artery in a Histokinette (Tissue-TEK VIP 
E3000) over a 12-h period in xylene; then wash it with alcohol and finally with water under reduced pressure.
7| Immerse the artery in decalcifier at 37 °C and test for complete decalcification periodically by extracting a 2-ml  
sample of decalcifier surrounding the artery and mixing with 1 ml of ammonium oxalate (5%, vol/vol) and 1 ml of ammonia 
(5%, vol/vol). If the solution becomes milky, decalcification is incomplete and the sample should be immersed in a new 
solution of decalcifier. Test for complete decalcification twice a day until it yields a clear, colorless solution.
8| Dehydrate and embed the artery in paraffin, as described in Steps 2 and 3.
? troublesHootInG
9| In the conventional and XGI phase SRµCT setups used, a sample diameter of <1 cm is preferred, as it facilitates the  
collection of high-resolution data. Minimize the sample diameter by, e.g., trimming the paraffin to roughly the diameter  
of the artery with a scalpel (taking care not to cut too close to the artery itself), and then rubbing the surface to smooth 
any uneven areas. This prevents air bubbles from forming on the paraffin surface during XGI phase SRµCT when the sample  
is immersed in a water tank. Any bubbles, even microscopic ones, can lead to strong artifacts in XGI phase SRµCT data.  
An example of an artery prepared in this manner is shown in Figure 2.
? troublesHootInG
Measurement: absorption srmct for decalcified artery ● tIMInG ~4 h per height step
10| Conduct data acquisition at a beamline with SRµCT setup optimized for absorption contrast mode (as in Step 3,  
above, see table 1). As the highly X-ray-absorbing plaque has been removed, lower energies can be used to improve the 
contrast between soft tissues (table 1).
? troublesHootInG
Measurement: XGI phase srmct for decalcified artery ● tIMInG ~7 h per height step
11| Conduct data acquisition at a beamline with the setup optimized for XGI phase-contrast mode. To image sections  
of the artery that are larger than the height of the beam (i.e., larger than the field of view), acquire multiple scans at  
different height positions (table 1). In our case, we acquired two slightly overlapping height steps to image the whole  
artery. A detailed description of grating interferometry and of the phase-stepping method is given by Weitkamp et al.20.
? troublesHootInG
Box 2 | Charges for acquiring tomograms at synchrotron radiation sources 
The cost of synchrotron radiation-based tomography varies depending on the synchrotron and funding options available. Beamtime can be 
applied for by submitting a proposal for peer review, or it can be paid for to guarantee rapid access. Applicants whose beamtime proposals 
are accepted use the facilities free of charge and conduct the measurements on their own once they have received a short training by the 
beamline staff (typically half a day). Paid access has a shorter waiting time, and data can be acquired and processed by the beamline staff 
for an extra cost. Unlike in proposal-based beamtime, there is no obligation to publish the results. The cost for paid access varies slightly, 
but it is usually charged in shifts of a fixed time, e.g., 8 h costing USD $5,500, depending on whether the users operate the experiment 
themselves or require the beamline staff to acquire and process the data. Note that, contrary to absorption tomography, phase tomography 
currently still requires assistance from experts in the method in planning, setting up and executing such measurements.
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preparation of histology slides ● tIMInG ~2 d for 30 slides
12| Slice the paraffin-embedded, decalcified artery into 2–4-µm lateral sections forming a paraffin ribbon with the arterial 
slices embedded therein. Maintaining the artery in the same paraffin embedding material minimizes the risk of morphologi-
cal changes between µCT measurements and histological preparation. As it is far too time-consuming to prepare a slide from 
every slice made, mount, for example, every 20th slice from the paraffin on a glass slide. Keep the remaining slices in case 
further analysis or slide preparation is required.
? troublesHootInG
13| Stain the slices with H&E.
 crItIcal step H&E stains the cell nuclei blue and nonspecifically stains intercellular and intracellular proteins pink.  
To further analyze the tissue types present, consider using other stains such as Masson’s Trichrome to distinguish cells from 
connective tissue and Miller stain to distinguish elastic fibers and collagen.
? troublesHootInG
Measurement: 2D histology slices ● tIMInG ~1 d 
14| Photograph the slices mounted on glass slides by using a microscope and a camera (we used a Nikon Eclipse 80i microscope 
at tenfold magnification). For improved spatial resolution, we photographed each slide in an average of 20 sections and stitched 
the images together by using the Stitching plug-in56 available in the Fiji software (ImageJ version 1.45k)57. This results in  
high-resolution color images of ~4,500 × 5,500 pixels, with a pixel size of 0.5 µm.
analysis and comparison of results ● tIMInG 2 weeks (working time)
15| To compare absorption and XGI phase SRµCT of decalcified arteries, a registration of the data sets using a 3D rigid  
algorithm58,59 with 6 d.f.—three for translation and three for rotation—should be sufficient for a solid state. Register the 
data sets by using a 3D affine algorithm with another 3 d.f. (scaling factors) in order to compensate for the mismatch in 
individual pixel sizes at different SR facilities. Because the imaging modalities are different, preferentially perform the  
3D registration by using the classical maximization of mutual information36,37. All registration steps can be automated;  
however, an appropriate starting point for the registration should be identified during a preliminary manual registration.  
This allows faster automated registration and avoids problems such as mirrored data sets.
16| Compare 3D SRµCT data sets with histology slices by performing a 2D-2D nonrigid registration of the individual histology 
slices (Fig. 5) with the appropriately selected slice from the 3D-registered phase-contrast SRµCT data set. For this, we used 
a code developed by Kroon and Slump60 in MATLAB 2010b (multimodality nonrigid demon algorithm image registration).
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Figure 5 | Histograms, cross-sectional tomograms, and histological slices 
show different tissue types. (a–h) Cross-sectional slices from absorption 
SRµCT (c) and XGI phase SRµCT (d) are comparable. However, d shows 
greater dynamic range in the soft-tissue region, with different tissue types 
validated by comparison with the corresponding H&E-stained histology 
slide (e). (a,b) Histograms of 3D reconstructions from absorption SRµCT (a) 
and XGI phase SRµCT (b) confirm that XGI phase SRµCT also provides more 
detailed information about the anticipated soft tissues present in the 3D 
data set, and that c and d are typical tomography slices. In absorption  
SRµCT (a), one can only distinguish between the paraffin (peak 1); soft 
tissues, including muscle, fat and fibrous cap (peak 2); and artifacts caused 
by residual plaque (slight hump on right hand side of peak 2). (f) The 
same slice with annotations highlights the artifact caused by an entrapped 
air bubble in the paraffin embedding (white circle) and the origin of the 
two observed streak artifacts caused by highly absorbing species, where 
decalcification is incomplete (black arrows). In XGI phase SRµCT (b),  
one can additionally distinguish between the soft tissues, i.e., paraffin and 
lumen (peak 1); foamy cells, cholesterol, epithelium (fine, well-defined 
outline of vessel lumen) and adventitia (peak 2); muscle and fibrous cap 
(peak 3); and residual plaque artifacts (peak 4). (g) This is illustrated in a 
false-color representation (see also Holme et al.7). Here, the white circle 
highlights an air bubble, and the white arrow points to the streak artifact 
that this causes in XGI phase SRµCT images; peak 1 is black, peak 2 is 
yellow, peak 3 is gray to white and peak 4 is red to blue. (h) Finally, these 
tissues are also identified on the H&E-stained histology slide, prepared by 
maximizing the contrast in each color channel, with the lumen (h, indicated 
by i), region of foamy cells and cholesterol (h, indicated by ii) and residual 
plaque with calcification (h, indicated by iii) outlined. 
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converting voxel-based data to vector-based data
 crItIcal The absorption SRµCT data form a solid  
grounding for clinically relevant flow simulations from which 
the endothelial shear stress distribution (time-averaged wall 
shear stress, AWSS) can be derived61. The voxel-based tomography data, however, are noisy because of the limited  
photon statistics52, and they have to be converted into a vector-based format as commonly used for simulations. After the 
segmentation of the lumen, a mesh must be extracted.
17| Use the region-growing tool in VGStudio Max 2.1 to select a seeding point far from visible artifacts. Conduct the  
lumen segmentation in a step-wise manner, adapting the sensitivity by visual inspection (we used sensitivity levels varying 
between 20 and 30 a.u.).
18| Next, convert the extracted voxel-based data of the lumen to a triangular mesh of the lumen surface in stl format,  
by using the Export function in VGStudio Max 2.1 (Fig. 6, left). Original voxel-based data are shown in Figure 7.
19| Smooth the lumen surface by using the ‘Polygons’ → ‘Relax Polygons’ tool in Geomagic Studio 12 with the settings  
‘smoothness level’ and ‘strength’ = medium, and ‘curvature priority’ = maximum. This smooths the surface by decreasing  
the angles between individual triangles of the mesh. Planarize inlet and outlet boundaries (Fig. 6, middle).
20| Use the automatic ‘Polygons’ → ‘Mesh Doctor’ tool in Geomagic Studio 12 to remove individual artifacts such as  
non-manifold edges, self-intersections, spikes, small holes and tunnels, as well as highly creased edges. Further smooth  
the surface by using the ‘Polygons’ → ‘Relax Polygons’ tool in Geomagic Studio 12 with ‘smoothness level’, ‘strength’,  
‘curvature’ = maximum. Finally, define planarized boundary conditions for the bifurcations, if present (Fig. 6, right).
21| From the resulting lumen surface, generate a volumetric tetrahedral computational grid, e.g., by using an octree  
method in ANSYS ICEM CFD (ANSYS).
22| For accurate calculation of wall shear stress (WSS) at a minimal computational cost, refine the mesh at the vicinity of 
the arterial wall and gradually coarsen toward the lumen center.
23| Successively refine the computational mesh and compare the WSS obtained at each refinement step to test whether the 
computational results are independent of the spatial discretization. The procedure is terminated when the values between 
two refinements differ by <1%.
Flow simulations
24| For flow simulations, extrude the inlet and outlet surface grids along their axes to five times the boundary diameter to 
allow flow to develop. This is common practice for uncertain boundary conditions62.
25| Solve the incompressible Navier-Stokes and continuity equations numerically in ANSYS CFX (ANSYS) to obtain the  
velocity and pressure fields within the artery. Regard blood as a Newtonian fluid with a density of 1,050 kg/m3 and  
viscosity of 0.0035 Pa·s (ref. 63), and use residual reduction to 10−8 of the initial value as the convergence criterion.
Figure 6 | The lumen mesh segmented from the absorption SRµCT data  
set requires further treatment before being used in flow simulations.  
Left, exported, triangulated surfaces of the segmented artery. Middle, surface 
smoothed and inlet-outlet boundary conditions defined. Right, individual 
artifacts removed, surface further smoothed and bifurcation boundary 
conditions defined. The distance between the arrowheads is 950 µm.
7.5 mm
Figure 7 | Cross-sectional reconstructed image of the lumen morphology 
extracted from absorption SRµCT showing the effective vessel lumen along  
a 7.5-mm-long section of a diseased human coronary artery at the 
bifurcation between the circumflex and the LAD artery (surface blue,  
inside yellow), soft tissues (semitransparent gray) and direction of blood 
flow (white arrow).
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26| Begin with steady-state simulations to obtain a first  
approximation of hemodynamics, and then perform  
transient calculations to analyze time-dependent flow and 
shear stress patterns.
27| For transient simulation (Fig. 8), select a suitable  
flat velocity profile with temporal waveform. Impose a zero-pressure boundary condition at the extended outlets of the 
computational model arteries. For less severely stenosed and larger artery segments than treated here, boundary conditions 
based on Murray’s Law or variations thereof should be applied to the outlets instead of zero pressure64. The artery studied in 
this protocol is the bifurcation between the circumflex and left anterior descending (LAD) coronary artery. Temporal wave-
forms from such diseased human LADs are unavailable in the literature, and thus we used data from a canine LAD coronary 
artery at rest, as used by La Disa et al.65 to model the effect of alterations in WSS distribution.
? troublesHootInG
Troubleshooting advice can be found in table 3.
Figure 8 | AWSS derived from the transient flow simulations by using the 
absorption SRµCT data, as prepared for Figure 7. Blue-colored regions show 
similar AWSS as healthy arteries (<5 Pa). Green-colored regions are larger 
than those observed in the healthy body (7–12 Pa). Yellow- and red-colored 
regions indicate markedly stenosed areas (>13 Pa), with AWSS values being 
one order of magnitude higher than those typically observed in the healthy 
vascular system. Length along the vessel section is 7.5 mm.
table 3 | Troubleshooting table.
step problem solution
4A(ii) Beam-hardening artifacts as seen by cupping  
(i.e., apparently higher absorption at the  
specimen’s periphery)
Use a metal filter such as aluminum or copper to narrow the spectrum by 
increasing the mean X-ray energy at constant maximal X-ray energy
4B(ii), 10, 
11
Streak artifacts from highly X-ray–absorbing  
species (even after decalcification)
Increase the energy of the incident X-ray beam
4, 10, 11 Undesired specimen movement (relative or 
rotational/translational)
Stop measurement, improve the fixation and restart the measurement. 
Consider the inertia of the specimen within the liquid environment
8, 9 Air bubbles embedded in the paraffin Re-embed with slower cooling or reduced pressure. If possible,  
check for the presence of air bubbles using a benchtop µCT setup  
(e.g., SkyScan 1174) before making time-consuming measurements  
at synchrotron facilities
11 Bubbles formed between paraffin block and  
water bath
Rub the paraffin to smooth the surface
12, 13 Pleats or folds in the histology slices Use a neighboring slice from the stored histology ribbon
● tIMInG
In terms of time, there are two main crucial factors. First, beamtime at the desired synchrotron radiation facility must  
be planned well in advance for both absorption and phase tomography. Second, tissue preparation is time-consuming 
because it includes diffusion-limited processes for fixation and staining. The time for histology, which includes cutting  
and staining, depends on the number of histological slides to be prepared. Below are the timings that we typically use in  
our measurements.
Steps 1–3, artery extraction, fixation and embedding: 48 h per artery. Several arteries can be collected in one session
Step 4A, benchtop µCT of nondecalcified artery: 75 min per height step (data reconstruction: 1 h per artery)
Step 4B, absorption SRµCT of nondecalcified artery: 3 h 40 min per height step for data collection (several height steps are 
needed). Data reconstruction takes 2 h per height step. The total number of height steps depends on artery length and X-ray 
beam height
105 150
AWSS (Pa)
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Steps 5–7, artery decalcification: 12 h to several days per artery (depends on the initial degree of calcification)
Steps 8 and 9, re-embedding in paraffin: 6 h per artery (several arteries can be prepared simultaneously)
Step 10, absorption SRµCT of decalcified artery: as in Step 4B
Step 11, XGI phase SRµCT of decalcified artery: 6 h per height step for tomography (several height steps are needed). Data 
processing for phase-projection images takes 3 h, and data reconstruction takes 4 h 30 min per height step. Note that we 
used our in-house reconstruction tool and computer for the XGI phase SRµCT reconstruction (see Equipment). Provided the 
same reconstruction tool and computer are used, the time taken to reconstruct similarly sized absorption and phase SRµCT 
data sets is comparable. The total number of height steps depends on artery length and X-ray beam field of view
Steps 12 and 13, preparation of histology slices: 2 d for cutting and staining (for 30 histological slices mounted on suitable 
glass substrates)
Step 14, 2D histology slides: 1 d for microscopy and postprocessing (stitching) of digital slices
Steps 15–27, analysis of results and flow simulations: 2 working weeks, including automatic 3D data registration
antIcIpateD results
This protocol allows human or animal organs to be measured with micrometer precision. Without the deformation risk  
during histological slide preparation, very reliable information is given about morphology and plaque presence. Specifically, 
the nondestructive µCT techniques applied here can, in combination, give an indication of the location of plaques in soft 
tissues in 3D and enable us to identify and characterize soft-tissue components by their refractive indices. In the case of 
blood vessels, they can also give quantitative information about the percentage cross-section of the lumen over the whole 
measured area. Such results can therefore be used to characterize atherosclerosis severity in postmortem arteries in terms 
of percentage occlusion of arterial cross-sectional area and plaque vulnerability. Meshes extracted from imaging data of the 
vascular system (here, human coronary arteries) can directly be used for flow simulations or other simulation models.
We find that the SkyScan 1174 benchtop µCT allows plaque segmentation but does not give meaningful information  
about the soft tissues. The µCT data are therefore a useful preliminary screening tool to identify the 3D structure of the 
plaque and aid selection of diseased arteries. We find that the resolution of the lumen morphology is of highest quality in 
absorption SRµCT of decalcified arteries. In addition to having a smaller pixel size in comparison with the other methods,  
it presents artifacts that are due to the highly X-ray-absorbing plaque, whereas the XGI phase SRµCT artifacts originate from 
air bubbles formed during paraffin embedding (see example in Fig. 5). These air bubbles often occur at or near the lumen, 
and therefore they make simple extraction tools such as local intensity–based segmentation unfeasible.
In this protocol, the lumen morphology is extracted from the absorption SRµCT data set and used to quantify the  
extent of stenosis (Figs. 6 and 7). By using this approach for the specimens studied in our published work7, the  
maximum occlusion was found to have a surface area of 0.83 mm2, corresponding to an 85% stenosis by lumen  
cross-sectional area.
XGI phase SRµCT affords distinction between different tissue types. We are able to assign ∆δ values to the plaque  
artifacts (1 × 10−8 to 2 × 10−8), muscle and fibrous cap (0.25 × 10−8 to 0.75 × 10−8), and foamy cells, cholesterol,  
epithelium and adventitia (−1 × 10−8 to 0). Note that this is usually impossible in absorption contrast owing to the  
overlapping attenuation values and the presence of artifacts caused by the plaque. Note that the ∆δ values are specific  
to the experimental parameters. Donath et al.66 proposed converting these values to phase-contrast Hounsfield units 
(HU-phase) given by ∆d
dwater
1,000⋅ . This allows a standardized, quantitative comparison of phase shifts that are measured in
a variety of specimens by using different experimental parameters, and it has been used by, for example, Hetterich et al.67  
investigating tissue types found in human coronary arteries. HU-phase values calculated from the ∆δ values reported  
above are 23–46 HU-phase (plaque artifacts), 5–17 HU-phase (muscle and fibrous cap) and −23–0 HU-phase (foamy  
cells, cholesterol, epithelium and adventitia). These are slightly lower than the values found by Hetterich et al.67, which 
is probably due to the methods used for segmenting the tissues, specimen preparation and variations in artery structure 
between patients.
Histology provides a gold standard for confirming the tissues; see, for example, 2D images (Fig. 5). However, constructing a 
3D image stack of the histology images is not trivial. Because of the pleats and different orientations of the individual slices 
in the histology slides, it is impossible to stack them automatically to create a 3D image by using software such as VGStudio 
or Fiji. Therefore, we overlaid the images manually in Adobe Photoshop C5, taking the artery lumen as the reference point, 
and then stacked them to give a 3D representation with VGStudio Max 2.1. We find that the quality of the 3D morphological  
data is substantially compromised by the unavoidable pleats in individual slices produced during the cutting process.  
In addition, histology provides a poor axial resolution (here, the distance between each prepared H&E-stained histology  
slide is 400–800 µm) and error in the manual image overlay when stacking. However, the individual slices are indispensable 
for validation of tissue characterization with XGI phase SRµCT data. In combination, XGI phase SRµCT and histology can be 
used to build up a 3D picture of the size and location of tissue types present, and the plaque stability can be qualified.
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An example of spatial distribution of AWSS after three cardiac cycles (see PROCEDURE Steps 24–27) is shown in Figure 8. 
In this experiment, an increase of AWSS is observed from less than 3 Pa in the least-constricted to 18 Pa in the  
most-stenosed areas. This example illustrates that the imaging data are sufficiently detailed to perform meaningful  
flow simulations after further data processing.
acknoWleDGMents This work was primarily funded by the Swiss National 
Science Foundation (SNSF) in the National Research Program (NRP) 62 ‘Smart 
Materials’ framework within the project number 406240_126090 ‘NO-Stress’. 
Synchrotron beamtime from the ESRF (MD-498 and MI-983) and the HASYLAB 
at DESY (I-20100181 EC) is gratefully appreciated. We thank K. Pu¨schel of the 
Institute of Forensic Medicine, University Medical Center, Hamburg-Eppendorf, 
who provided the human arteries. T.W. acknowledges support from the French 
research networks (RTRA) ′Digiteo′ and ′Triangle de la Physique′ (grants 2009-
034T and 2009-79D), and V.K. acknowledges support from SNSF through the 
Swiss National Centre of Competence in Research (NCCR) Kidney.CH. T.W. and 
B.M. acknowledge support from the Agence Nationale de la Recherche (France) 
via the EQUIPEX grant number ANR-11-EQPX-0031 (project NanoimagesX). 
M.N.H. and B.M. thank S. Hieber for training in image segmentation and for 
her contributions to the related part of the manuscript introduction. We further 
acknowledge the Karlsruhe Nano Micro Facility (KNMF) of the Karlsruhe Institute 
of Technology (KIT), Eggenstein-Leopoldshafen, Germany, and J. Mohr and his 
collaborators at the Institute for Microstructure Technology (IMT) of KIT for 
providing the analyzer grating.
autHor contrIbutIons M.N.H. and B.M. wrote the manuscript with sections 
provided by T.W. and V.K. G.S., I.Z., M.N.H. and T.W. set up and performed 
the phase-contrast SRµCT measurements. F.B., G.S., H.D. and M.N.H. set up 
and performed the absorption-contrast SRµCT measurements. G.S., H.D. and 
M.N.H. performed the benchtop µCT measurements. F.B., M.N.H., G.S. and H.D. 
performed data processing, reconstruction and analysis, excluding the flow 
simulations (Steps 21–27), which were performed by F.R. and V.K. Histology 
slides were prepared by J.A.L. T.S. and J.A.L. provided a clinical perspective 
for data analysis. T.W., J.A.L., V.K. and I.Z. provided technical and conceptual 
advice. B.M. and T.S. designed the study. All authors contributed to editing the 
manuscript, including tables and figures.
coMpetInG FInancIal Interests The authors declare no competing financial 
interests.
Reprints and permissions information is available online at http://www.nature.
com/reprints/index.html.
1. Lloyd-Jones, D. et al. Heart disease and stroke statistics—2009 update: a 
report from the American Heart Association Statistics Committee and 
Stroke Statistics Subcommittee. Circulation 119, e21–e181 (2009).
2. Knight, J. et al. Choosing the optimal wall shear parameter for the 
prediction of plaque location, a patient-specific computational study in 
human right coronary arteries. Atherosclerosis 211, 445–450 (2010).
3. Cheng, C. et al. Large variations in absolute wall shear stress levels within 
one species and between species. Atherosclerosis 195, 225–235 (2007).
4. Holme, M.N. et al. Shear-stress sensitive lenticular vesicles for targeted 
drug delivery. Nat. Nanotechnol. 7, 536–543 (2012).
5. Korin, N. et al. Shear-activated nanotherapeutics for drug targeting to 
obstructed blood vessels. Science 337, 738–742 (2012).
6. Goderie, T.P.M. et al. Combined optical coherence tomography and 
intravascular ultrasound radio frequency data analysis for plaque 
characterization. Classification accuracy of human coronary plaques  
in vitro. Int. J. Cardiovasc. Imaging 26, 843–850 (2010).
7. Holme, M.N. et al. Morphology of atherosclerotic coronary arteries.  
Proc. SPIE 8506, 850609 (2012).
8. Coombs, B.D., Rapp, J.H., Ursell, P.C., Reilly, L.M. & Saloner, D. Structure 
of plaque at carotid bifurcation high-resolution MRI with histological 
correlation. Stroke 32, 2516–2521 (2001).
9. Stock, S.R. Microcomputed Tomography: Methodology and Applications  
(CRC Press, 2008).
10. Drews, S. et al. Comparative micro computed tomography study of a 
vertebral body. Proc. SPIE 7078, 70780C (2008).
11. Germann, M. et al. Strain fields in histological slices of brain tissue 
determined by synchrotron radiation-based micro computed tomography.  
J. Neurosci. Meth. 170, 149–155 (2008).
12. Fitzgerald, R. Phase-sensitive X-ray imaging. Phys. Today 53, 23–26 
(2000).
13. Momose, A. Recent advances in X-ray phase imaging. Jpn. J. Appl. Phys. 
44, 6355–6367 (2005).
14. Momose, A., Takeda, T., Itai, Y. & Hirano, K. Phase-contrast X-ray 
computed tomography for observing biological soft tissues. Nat. Med. 2, 
473–475 (1996).
15. Beckmann, F., Bonse, U., Busch, F. & Günnewig, O. X-ray  
microtomography (µCT) using phase contrast for the investigation of 
organic matter. J. Comput. Assist. Tomo. 21, 539–553 (1997).
16. Förster, E., Goetz, K. & Zaumseil, P. Double-crystal diffractometry for the 
characterization of targets for laser fusion experiments. Krist. Tech. 15, 
937–945 (1980).
17. Davis, T., Gao, D., Gureyev, T., Stevenson, A. & Wilkins, S. Phase-contrast 
imaging of weakly absorbing materials using hard X-rays. Nature 373, 
595–598 (1995).
18. Koch, A., Raven, C., Spanne, P. & Snigirev, A. X-ray imaging with 
submicrometer resolution employing transparent luminescent screens.  
J. Opt. Soc. Am. A 15, 1940–1951 (1998).
19. Cloetens, P. et al. Holotomography: quantitative phase tomography with 
micrometer resolution using hard synchrotron radiation X-rays. Appl. Phys. 
Lett. 75, 2912–2914 (1999).
20. Weitkamp, T. et al. X-ray phase imaging with a grating interferometer. 
Optics Exp. 13, 6296–6304 (2005).
21. Koyama, I., Momose, A., Wu, J., Lwin, T.T. & Takeda, T. Biological  
imaging by X-ray phase tomography using diffraction-enhanced imaging. 
Jpn. J. Appl. Phys. 1 44, 8219–8221 (2005).
22. Schulz, G. et al. High-resolution tomographic imaging of a human 
cerebellum: comparison of absorption and grating-based phase contrast.  
J. R. Soc. Interface 7, 1665–1676 (2010).
23. Pfeiffer, F. et al. High-sensitivity phase-contrast tomography of rat brain 
in phosphate-buffered saline. J. Phys. Conf. Ser. 186, 012046 (2009).
24. Pfeiffer, F. et al. High-resolution brain tumor visualization using  
three-dimensional X-ray phase-contrast tomography. Phys. Med. Biol. 52, 
6923–6930 (2007).
25. Rikhtegar, F. et al. Compound ex vivo and in silico method for 
hemodynamic analysis of stented arteries. PLoS ONE 8, e58147  
(2013).
26. Galonska, M. et al. Characterization of atherosclerotic plaques in human 
coronary arteries with 16-slice multidetector-row computed tomography  
by analysis of attenuation profiles. Acad. Radiol. 15, 222–230 (2008).
27. Zachrisson, H. et al. Soft tissue discrimination ex vivo by dual energy 
computed tomography. Eur. J. Radiol. 75, e124–e128 (2010).
28. Müller, B. et al. Grating-based tomography of human tissues. AIP Conf. 
Proc. 1466, 107–112 (2012).
29. Pfeiffer, F., Weitkamp, T., Bunk, O. & David, C. Phase retrieval and 
differential phase-contrast imaging with low-brilliance X-ray sources.  
Nat. Phys. 2, 258–261 (2006).
30. Tapfer, A. et al. Experimental results from a preclinical X-ray phase-
contrast CT scanner. Proc. Natl. Acad. Sci. USA 109, 15691–15696 (2012).
31. Müller, B. et al. Three-dimensional evaluation of biocompatible materials 
by microtomography using synchrotron radiation. Proc. SPIE 4503,  
178–188 (2002).
32. Schulz, G. et al. Evaluating the microstructure of human brain  
tissues using synchrotron radiation–based micro-computed tomography. 
Proc. SPIE 7804, 78040F (2010).
2.1 A systematic protocol using multi-model micro-computed tomography for
uncovering the morphology and tissue composition of critically constricted human
coronary arteries 27
©
20
14
 N
at
ur
e 
A
m
er
ic
a,
 
In
c.
 
 
A
ll 
rig
ht
s 
re
se
rv
ed
.
protocol
nature protocols | VOL.9 NO.6 | 2014 | 1415
33. Schulz, G. et al. Multimodal imaging of human cerebellum—merging X-ray 
phase microtomography, magnetic resonance microscopy and histology. 
Sci. Rep. 2, 826 (2012).
34. Schulz, G. et al. Asymmetric rotational axis reconstruction of grating-
based X-ray phase-contrast tomography of the human cerebellum.  
Proc. SPIE 8506, 850604 (2012).
35. Herzen, J. et al. X-ray grating interferometer for imaging at a second-
generation synchrotron radiation source. Proc. SPIE 7804, 780407 (2010).
36. Maes, F., Collignon, A., Vandermeulen, D., Marchal, G. & Suetens, P.  
Multi-modality image registration maximization of mutual information. 
IEEE 16, 187–198 (1997).
37. Viola, P. & Wells, W.M. III Alignment by maximization of mutual 
information. Int. J. Computer Vision 24, 137–154 (1997).
38. Schulz, G. et al. Three-dimensional strain fields in human brain resulting 
from formalin fixation. J. Neurosci. Meth. 202, 17–27 (2011).
39. Stalder, A. et al. Combining micro computed tomography and histology  
to assess the efficacy of bone augmentation materials. Int. J. Mater. Res. 
doi:10.3139/146.111050 (2014).
40. Grabherr, S. et al. Angiofil: a novel radio-contrast agent for postmortem 
micro-angiography. Proc. SPIE 7078, 70781O (2008).
41. Müller, B., Fischer, J., Dietz, U., Thurner, P.J. & Beckmann, F. Blood vessel 
staining in the myocardium for 3D visualization down to the smallest 
capillaries. Nucl. Instrum. Meth. Phys, Res, B Beam Interact, Mater, Atoms 
246, 254–261 (2006).
42. Plouraboué, F. et al. X-ray high-resolution vascular network imaging.  
J. Microsc. 215, 139–148 (2004).
43. Stephenson, R.S. et al. Contrast enhanced micro-computed tomography 
resolves the 3-dimensional morphology of the cardiac conduction system 
in mammalian hearts. PLoS ONE 7, e35299 (2012).
44. Pai, V.M. et al. Coronary artery wall imaging in mice using osmium 
tetroxide and micro-computed tomography (µ-CT). J. Anat. 220, 514–524 
(2012).
45. Stockman, G. & Shapiro, L.G. Computer Vision 1st edn. (Prentice Hall PTR, 
2001).
46. Frangi, A.F., Niessen, W.J., Vincken, K.L. & Viergever, M.A. In Medical Image 
Computing and Computer-Assisted Intervention—Miccai’98, Vol. 1496 (eds. 
Wells, W.M., Colchester, A. & Delp, S.) 130–137 (Springer-Verlag, 1998).
47. Pratt, W.K. Digital Image Processing: Piks Scientific Inside (John Wiley & 
Sons, 2007).
48. Grodzins, L. Optimum energies for X-ray transmission tomography of  
small samples—applications of synchrotron radiation to computerized-
tomography 1. Nucl. Instrum. Methods 206, 541–545 (1983).
49. Thurner, P., Beckmann, F. & Müller, B. An optimization procedure for 
spatial and density resolution in hard X-ray micro-computed tomography. 
Nucl. Instrum. Meth. B 225, 599–603 (2004).
50. Müller, B. et al. Three-dimensional registration of tomography data for 
quantification in biomaterials science. Int. J. Mater. Res. 103, 242–249 
(2012).
51. Weitkamp, T. et al. Recent developments in X-ray Talbot interferometry  
at ESRF-ID19. Proc. SPIE 7804, 780406 (2010).
52. Beckmann, F., Herzen, J., Haibel, A., Müller, B. & Schreyer, A. High 
density resolution in synchrotron-radiation-based attenuation-contrast 
microtomography. Proc. SPIE 7078, 70781D (2008).
53. Huesman, R.H. RECLBL Library Users Manual: Donner Algorithms for 
Reconstruction Tomography (Lawrence Berkeley Laboratory, University of 
California, 1977).
54. Pfeiffer, F., Bunk, O., Kottler, C. & David, C. Tomographic reconstruction  
of three-dimensional objects from hard X-ray differential phase-contrast 
projection images. Nucl. Instrum. Meth. A 580, 925–928 (2007).
55. Weitkamp, T., David, C., Kottler, C., Bunk, O. & Pfeiffer, F. Tomography 
with grating interferometers at low-brilliance sources. Proc. SPIE 6318, 
63180S (2006).
56. Preibisch, S., Saalfeld, S. & Tomancak, P. Globally optimal stitching of tiled 
3D microscopic image acquisitions. Bioinformatics 25, 1463–1465 (2009).
57. Walter, T. et al. Visualization of image data from cells to organisms.  
Nat. Methods 7, 479–479 (2010).
58. Andronache, A., von Siebenthal, M., Székely, G. & Cattin, P. Non-rigid 
registration of multi-modal images using both mutual information and 
cross-correlation. Med. Image Anal. 12, 3–15 (2008).
59. Fierz, F.C. et al. The morphology of anisotropic 3D-printed hydroxyapatite 
scaffolds. Biomaterials 29, 3799–3806 (2008).
60. Kroon, D.-J. & Slump, C.H. MRI modality transformation in demon 
registration. IEEE International Symposium on Biomedical Imaging: From  
Nano to Macro, ISBI ‘09 (June 28–July 1, 2009, Boston, Massachusetts, USA) 
963–966 (2009).
61. Olgac, U., Poulikakos, D., Saur, S.C., Alkadhi, H. & Kurtcuoglu, V.  
Patient-specific three-dimensional simulation of LDL accumulation in a 
human left coronary artery in its healthy and atherosclerotic states.  
Am. J. Phys. 296, H1969–H1982 (2009).
62. Moyle, K.R., Antiga, L. & Steinman, D.A. Inlet conditions for image-based 
CFD models of the carotid bifurcation: is it reasonable to assume fully 
developed flow? J. Biomech. Eng. 128, 371–379 (2006).
63. Rikhtegar, F. et al. Choosing the optimal wall shear parameter for the 
prediction of plaque location—a patient-specific computational study in 
human left coronary arteries. Atherosclerosis 221, 432–437 (2012).
64. van der Giessen, A.G. et al. The influence of boundary conditions on wall 
shear stress distribution in patients specific coronary trees. J. Biomech. 
44, 1089–1095 (2011).
65. La Disa, J.F. et al. Alterations in regional vascular geometry produced by 
theoretical stent implantation influence distributions of wall shear stress: 
Analysis of a curved coronary artery using 3D computational fluid 
dynamics modeling. Biomed. Eng. Online 5, 40 (2006).
66. Donath, T. et al. Toward clinical X-ray phase-contrast CT demonstration  
of enhanced soft-tissue contrast in human specimen. Invest. Radiol. 45, 
445–452 (2010).
67. Hetterich, H. et al. Grating-based X-ray phase-contrast tomography of 
atherosclerotic plaque at high photon energies. Z. Med. Phys. 23,  
194–203 (2013).
68. Als-Nielsen, J. & McMorrow, D. Elements of Modern X-ray Physics  
(John Wiley & Sons, 2011).
28 2 Results
2.2 Comparison of the morphology of model and explanted human coronary
arteries 29
2.2 Comparison of the morphology of model and
explanted human coronary arteries
A combination of advanced laboratory and synchrotron radiation-
based micro tomography techniques are combined to non-destructively
study the 3D morphology of human, murine and PMMA model arter-
ies. The advantages and disadvantages of each technique are discussed.
Intensity-based and region-growing segmentation techniques allow the
cross-sectional areas and maximum constrictions to be calculated for
each artery. The PMMA model arteries are found to be a good mor-
phological approximation of the studied human coronary artery. The
murine artery however is not, and is unsuitable for flow simulations.
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ABSTRACT 
Atherosclerosis, the narrowing of vessel diameter and build-up of plaques in coronary arteries, leads to an increase in the 
shear stresses present, which can be used as a physics-based trigger for targeted drug delivery. In order to develop 
appropriate nanometer-size containers, one has to know the morphology of the critical stenoses with isotropic 
micrometer resolution. Micro computed tomography in absorption and phase contrast mode provides the necessary 
spatial resolution and contrast. The present communication describes the pros and cons of the advanced laboratory and 
synchrotron radiation-based approaches in the visualization of diseased human and murine arteries. Using registered 
datasets, it also demonstrates that multi-modal imaging, including established histology, is even more powerful. The 
tomography data were evaluated with respect to cross-section, vessel radius and maximal constriction. The average 
cross-section of the diseased human artery (2.31 mm2) was almost an order of magnitude larger than the murine one 
(0.27 mm2), whereas the minimal radius differs only by a factor of two (0.51 mm versus 0.24 mm). The maximal 
constriction, however, was much larger for the human specimen (85% versus 49%). We could also show that a plastic 
model used for recent experiments in targeted drug delivery represents a very similar morphology, which is, for example, 
characterized by a maximal constriction of 82%. The tomography data build a sound basis for flow simulations, which 
allows for conclusions on shear stress distributions in stenosed blood vessels. 
Keywords: Atherosclerosis: vessel morphology, shear stress, human coronary artery, mouse model, plaque, micro 
computed tomography, phase tomography, histology 
 
1. INTRODUCTION  
Cardiovascular disease is the number one cause of morbidity and mortality in modern society. In 2008 it was responsible 
for 30% of all deaths globally [1]. The disease is characterized by the natural progression of lesion formation followed 
by lipid core expansion, macrophage accumulation and finally formation of a fibrose cap [2]. In the latter stages, the 
arteries become increasingly rigid and significantly stenosed due to the space occupied by the diseased tissue. In the 
acute case of plaque rupture, i.e. myocardial infarction (MI), the vasodilator nitroglycerine is often administered to open 
up and widen the stenosed arteries to allow for the reperfusion of blood before ischemic events. Unfortunately, owing to 
the systemic effect of such vasodilators, their administration has to be carefully monitored or withdrawn prematurely to 
minimize the unavoidable side effects such as systemic hypotension. 
It is well known that the constriction in critically stenosed arteries leads to local endogenous shear stresses that are 
significantly higher than those found in the healthy vascular system [3]. Encapsulating the vasodilators (nitroglycerine) 
in shear-sensitive nanocontainers, e.g. liposomes [4], could alleviate these problems. Targeting shear stresses such as 
those found in, for example, an 80%-stenosed artery would ensure the drug is delivered to the diseased artery but 
significantly less to the surrounding healthy vascular system. In order to better understand the local shear stress changes 
using flow simulations, the morphology of critically stenosed arteries must be uncovered down to the micrometer level. 
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The imaging of plaque-containing arteries is challenging, as the simultaneous artifact-free visualization of hard and 
soft tissue components needs precise knowledge on the preparation including embedding and on the choice of imaging 
modalities and parameters. Nevertheless, micro computed tomography (µCT) is one of the most powerful techniques that 
enable the experimentalist to nondestructively image microstructures with isotropic resolution in the three-dimensional 
(3D) space. The presence of the plaque within the blood vessels means that higher photon energies are required to avoid 
streak artifacts. This choice, however, leads to a decrease in the density resolution of the soft tissue components since 
higher energy X rays exhibit much less interaction probability in the conventional absorption contrast. In synchrotron-
radiation based µCT in phase contrast mode (phase tomography) using hard X rays this dependence is much weaker [5]. 
Therefore, phase tomography might be much better suited to visualize the plaque-containing stenosed arteries. 
Here, we report data on human and mouse arteries acquired using µCT. Micro computed tomography using a 
conventional or advanced laboratory setup (laboratory µCT) provides a user-friendly imaging modality that can be rather 
easily implemented in a research lab, and is suitable for segmenting the lumen morphology and understanding the extent 
of stenosis in a given vessel. It is also well suited to investigate plastic models of the human vascular system such as 
those recently applied to demonstrate the efficacy of nanocontainers in targeted drug delivery [4]. One can quantify the 
degree of occlusion in a polymethylmethacrylate (PMMA) model of the diseased situation with respect to the healthy 
morphology. Subsequently the model data can be quantitatively compared with the actual morphology of stenosed 
human or animal arteries. In search of an animal model for further testing of targeted drug delivery and following the 
advice of international experts, we measured two mouse abdominal aortas using phase SRµCT. One has to recognize that 
mice have an intrinsically higher shear stress due to their smaller vessel sizes. It is, however, rather simple to breed 
plaque in their arteries. Tomography data can be the basis of flow simulations to determine how far experiments with 
small animals resemble the situation of patients. 
Phase tomography [6, 7] provides significantly better contrast in soft tissues than both advanced laboratory µCT and 
SRµCT in absorption contrast mode. Therefore, this approach allows the differentiation between several tissue types 
similar to well-established histology. We know, however, that the combination of imaging techniques, often termed 
multi-modal imaging, is even more powerful. In this communication on human coronary arteries we show registered 
slices of multi-modal imaging. 
2. MATERIALS AND METHODS 
2.1 PMMA model 
Previous in vitro studies to evaluate the shear stress sensitivity of nanometer-size vesicles were based on a flow system 
akin to the human vascular system [4]. The aim of this previous study was to identify lipid formulations that react to 
endogenous shear stresses in stenosed human coronary arteries as a physical release trigger. For this reason, a PMMA 
model (Elastrat, Lausanne, Switzerland) of a healthy and diseased artery was built and incorporated into the experimental 
setup. To assess the morphology of this model and to quantitatively compare it with human vessel morphology, it was 
visualized using an advanced laboratory µCT by means of a nanotom m (Phoenix|x-ray, GE Sensing & Inspection 
Technologies GmbH, Wunstorf, Germany) using a 180 kVp / 15 W nanofocus X-ray source. The model was measured 
with an accelerating voltage of 120 kVp, a beam current of 100 µA, and 2 s exposure time, with a 0.2 mm aluminum 
filter to increase the mean photon energy. 1000 equiangular projections were recorded over 360° in a field of view of 
1300 × 2400 pixels, pixel size 25 µm. Reconstruction of the projections was carried out using a cone beam filtered back-
projection algorithm of phoenix datos|x 2.0.1 - RTM (GE Sensing & Inspection Technologies GmbH, Wunstorf, 
Germany). The reconstructed 3D dataset contains 16-bit values, which correlate to the local X-ray absorption in the 
specimen. 
2.2 Mouse aortas 
Apolipoprotein E deficient mice (ApoE-/-) in a C57BL/6J background were obtained from the Charles River 
Laboratories. At eleven weeks of age, two males were fed with a high-cholesterol diet (HCD; 1.25% cholesterol) for an 
additional eleven weeks. Then, the animals were euthanized and perfused for five minutes with phosphate buffer saline 
before the abdominal aortas were collected [8]. These tissues were immediately immersed in 4% paraformaldehyde 
(PFA) fixative for 24 h before analysis. This protocol was approved by the local ethical committee and Swiss authorities 
as well as conformed to the ‘position of the American Heart Association on Research Animal Use’.	
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The phase tomography measurements were carried out using a Talbot-Lau interferometer at the beamline W 2 
(HASYLAB at DESY, Hamburg, Germany), operated by the HZG Research Center [6, 9]. The grating interferometer 
consisted of three gratings: the source grating (period 22.9 µm; gold height 130 µm), the phase grating (period 4.33 µm; 
silicon height about 60 µm) and the analyzer grating (period 2.4 µm; gold height: 150 µm). Source and phase gratings 
were fabricated at the Paul Scherrer Institut (Villigen, Switzerland). The analyzer gold grating was produced at the 
Karlsruhe Institute of Technology (Karlsruhe, Germany). The photon energy was set to 31 keV corresponding to the 
third fractional Talbot order. The X-ray detector consisted of a ~ 580 µm-thick CdWO4 scintillator lens-coupled to a 
CCD camera. The PL09000 CCD camera (Finger Lakes Instrumentations, New York, USA) had an active area of 
3056 × 3056 pixels, pixel size 12 µm. For each projection a phase-stepping scan was performed, in which a set of images 
at eight different positions of the phase grating over two periods was recorded. The moderate optical magnification of 
5.41 gave rise to an effective pixel size of 2.22 µm with a field of view of 6.77 × 6.77 mm2. The spatial resolution 
determined from a highly absorbing edge in absorption mode was 5.18 µm [10]. Tomographic reconstruction was 
performed using a modified filter kernel in combination with standard filtered back-projection algorithm [6, 11]. 
2.3 Multi-modal imaging of atherosclerotic human coronary arteries  
Two 2.5 cm-long sections from different human coronary arteries were explanted post mortem at the Institute of Forensic 
Medicine, University Medical Center, Hamburg-Eppendorf. They were subsequently immersed in 4% PFA fixative for 
more than 10 h, then dehydrated by soaking under reduced pressure overnight in alcohol followed by xylene after which 
it was immersed in molten paraffin (60 °C) and cooled to room temperature. After SRµCT-measurements (not reported 
here), the paraffin was removed by heating the artery to 60 °C then washing in a Histokinette (Tissue-TEK VIP E3000) 
for 12 h under reduced pressure in xylene, alcohol then water. The artery was immersed in decalcifier (distilled 
water : formic acid : PFA, 87 : 8 : 5 v/v) at a temperature of 37 °C for two days. After complete decalcification, a 
2 mL sample of decalcifier in which the artery is immersed does not become milky if mixed with 1 mL ammonium 
oxalate (5%) and 1 mL ammonia (5%). The artery was then dehydrated and immersed in molten paraffin as described 
above. Once the paraffin had cooled, the block was trimmed to the part containing the artery and smoothed by rubbing to 
avoid air bubbles on the surface during measurement. 
Advanced laboratory µCT: The morphology of a human coronary artery was assessed first by laboratory µCT 
using a nanotom m (Phoenix|x-ray, GE Sensing & Inspection Technologies GmbH, Wunstorf, Germany) and 
180 kVp / 15 W nanofocus X-ray source, analogously to the PMMA model described above. An accelerating voltage of 
60 kVp, a beam current of 310 µA, and 1.2 s exposure time were used together with a 0.5 mm-thick aluminum filter to 
increase the mean photon energy. 1000 equiangular projections were measured over 360°. The field of view was 
1300 × 2400 pixels, pixel size 17.78 µm. Reconstruction of the projections was carried out using a cone beam filtered 
back-projection algorithm of the software phoenix datos|x 2.0.1 - RTM (GE Sensing & Inspection Technologies GmbH, 
Wunstorf, Germany) with a ring artifact removal routine. 
Absorption SRµCT: The absorption contrast-based SRµCT measurement was carried out at the beamline BW 2 
(HASYLAB, DESY, Germany) operated by the Helmholtz-Zentrum Geesthacht [12]. The highly intense, collimated X-
ray beam was monochromatized by means of a fixed-exit double crystal monochromator (Si(111)-crystals) to realize a 
photon energy of 14 keV with a bandwidth of 0.01%. The tomography set-up was installed 40 m from the radiation 
source and consisted of the sample manipulator and two-dimensional detection unit. The sample manipulator was used 
for both precise sample rotation and sample translation, so the photon distribution within the X-ray beam could be 
recorded without specimen for normalization. The X-ray detection unit was a luminescent screen (500-µm-thick CdWO4 
single crystal), optical lens (Nikkor 35 mm focal length, Nikon Inc., Tokyo, Japan), and charge-coupled device (CCD) 
camera (KX2, Apogee Instruments Inc., Roseville, CA, USA, 14-bit digitization at 1.25 MHz, 1536 × 1024 pixels, pixel 
size 9 µm. The incident X rays were converted into visible light by the luminescent screen, projected with the 
magnification of 3.05 onto the CCD chip [13] resulting in an effective pixel size of 2.95 µm. To increase photon 
statistics, and therefore the contrast in the reconstructed slices, projections were binned by a factor of two [14]. The 
spatial resolution determined from a highly absorbing edge was 5.28 µm [11]. 
Phase tomography: The phase tomography measurement was carried out at the beamline ID 19 (ESRF, Grenoble, 
France). Artifacts were expected by the strong phase shift at the surface of the artery-containing paraffin block with 
surrounding air, caused by the prominent difference in decrement of the refractive indexes. To minimize related artifacts, 
the specimen was immersed in a water bath with parallel PMMA plates arranged perpendicular to the incoming X-ray 
beam. To ensure that no air bubbles formed on the specimen’s surface, it was smoothed by rubbing gently before 
immersion in the bath. A photon energy of 23 keV was selected using a double-crystal Si(111) monochromator in Bragg 
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geometry. The specimen was situation 10 cm upstream from the beam-splitter grating (4.785 µm periodicity, 29 µm Si 
structure height). With a distance between source and interferometer of 150 m and a distance between the gratings of 
481 mm (ninth Talbot order), the ratio of the grating periods was matched to the beam divergence [15]. The detector, 
placed about 3 cm downstream of the analyzer grating with a periodicity of 2.400 µm and a structure height of 50 µm, 
was a lens-coupled scintillator and CCD system using a FReLoN 2K (Fast-Readout, Low-Noise, ESRF Grenoble, 
France) CCD with 2048 × 2048 pixels. The effective pixel size corresponded to 5.4 µm. The field of view was 
10.4 × 11.0 mm2. Projection radiographs were taken at taken at an angular step size of 0.36° (999 intervals over 360° 
scan range), with 1.2 s exposure time. At each projection angle, four phase-stepping images were taken over one period 
of the interferometer fringe pattern. The reader is referred to the literature for detailed descriptions of grating 
interferometry and of the phase-stepping method [7] and for the details of the instrument used in this study [16]. The 
phase-contrast projection dataset was reconstructed using a modified filter kernel (Hilbert transform) in combination 
with a standard filtered back-projection algorithm [17-19]. 
Histology: The paraffin embedded artery was prepared into 2 to 4 µm-thin lateral sections. Maintaining the artery in 
the same paraffin embedding ensured the unchanged morphology between µCT-measurements and histological 
preparation.  Since it is time consuming to prepare each slice, the preparation of all sequential slices is impossible within 
a reasonable time frame. Therefore, every 20th slice from the paraffin ribbon was mounted on a glass slide and stained 
with Hematoxylin and Eosin (H&E) stain. Each slice was photographed using a Nikon Eclipse 80i microscope and 
camera at 10× magnification in an average of 20 sections, which were stitched together using the stitching plug-in [20] 
available in Fiji software (ImageJ version 1.45k, EMBL, Germany) [21] to give color images of on average 4500 × 5500 
pixels, pixel size 0.5 µm. 
3. RESULTS 
3.1 PMMA model artery 
In the center of Figure 1 the model with the two channels that represent a healthy vessel and an atherosclerotic human 
coronary artery are displayed. One easily recognizes the morphology of the diseased vessel on the left and the 
morphology of the healthy vessel on the right. The lumen is easily extracted by means of thresholding [22]. The cross-
sectional area of the lumen for each vessel in the individual slices is determined using computer code (MATLAB 
R2010b). The right diagram in Figure 1 with the graph in red color shows the variation of the cross-section as a function 
of position (height). The value varies by a maximum of 7% between 6.04 and 6.49 mm2. The diagram on the left in 
Figure 1 with the blue-colored graph corresponds to the diseased vessel and the cross-sectional area fluctuates between 
1.17 and 6.43 mm2, which is more than a factor of five. This means that the maximal cross section in both cases is 
identical within the error bars, whereas the minimal cross sections differ by more than a factor of five. 
 
Figure 1. Cross-sectional area of the inner volume of a diseased (left) and healthy (right) artery model derived from 
laboratory µCT measurements. In the center, the data are represented as 3D rendering. 
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3.2 Mouse aortas 
The mouse abdominal aortas were investigated using synchrotron radiation-based phase tomography to determine their 
morphology on the micrometer scale. The vessel walls exhibited a larger real part of the refractive index in comparison 
with the surrounding tissues and PFA solution in the Eppendorf container. Thus, it was rather simple to segment the 
lumen (see Figure 2) using the region-growing tool in VG Studio Max 2.1 (Volume Graphics, Heidelberg, Germany). 
The associated 3D renderings in Figure 2 were generated in VG Studio Max 2.1 by means of thresholding [22] and 
rendered using the settings Volume Renderer (Scatter HQ) (Figure 2, top, bisected artery) and Scatter HQ (v1.2) (Figure 
2, bottom left). 
 
Figure 2: Morphology of a stenosed mouse aorta from a phase SRµCT measurement. Top, left to right: diagram of the cross 
sectional area of the lumen with axes comparable to the diagrams in Figure 1, 3D rendering of the artery bisected and 
opened up down the middle, with two selected cross-sectional slices. Bottom left to right: 3D rendering of the entire 
mouse aorta, histogram of the 3D tomography data to elucidate differences in the real part of the refractive index. 
Unfortunately, it was impossible to differentiate between the expected plaque and the arterial wall tissue. The 
histogram in Figure 2 only exhibits a shoulder of the main peak that might be caused from plaque formed. The hole 
easily recognized in the artery wall resulted from a bifurcation. Here, the vessel was trimmed off during specimen 
preparation. 
The lumen of the mouse aorta has a cross-sectional area that ranges from 0.19 to 0.37 mm2. This means that the 
variation is below 50%. The 3D rendering illustrates that the lumen is rather straight and does not resemble the 
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morphology of a common stenosis in man. The periodic ripples along the vessel are artifacts that originate from 
insufficient background correction and can be removed by post-processing, which was not performed for the presented 
dataset. 
3.3 Imaging an atherosclerotic human coronary artery 
Three selected slices from the phase tomography and laboratory µCT were successfully registered in 2D space (Figures 3 
and 4). This is a prerequisite to directly compare the performance of the two techniques. Registration was performed 
using a code developed by Kroon and Slump (multimodality non-rigid demon algorithm image registration [23]) in 
MATLAB 2010b with a scaling factor in the affine non-rigid registration. The two approaches provide similar 
information about the different tissue types and the paraffin embedding. Comparing the selected slices from the two 
approaches, however, the distinction is clearer in phase tomography than in the conventional µCT data. This qualitative 
observation is corroborated using the joint histograms represented between the slices. They are almost symmetric along 
the diagonal, a sign that both approaches are comparable in performance. One can clearly distinguish the paraffin (a), the 
soft tissues including muscles (b), and the plaque (c). The peaks of the components, however, have different half widths. 
For example, the paraffin peak is narrower for the phase tomography than for the advanced laboratory µCT, giving rise 
to an oval shape in the joint histogram (a). 
 
Figure 3. Comparison of phase tomography using synchrotron radiation and laboratory µCT for the extraction of lumen 
morphology. A and B show for two selected slices of the phase tomography (left), the joint histogram (center) and the 
laboratory µCT data (right). The joint histograms can be used to segment tissues by comparing the different gray-scale 
values in the slices, i.e. paraffin (indicated by a), muscle and soft tissues (b), and plaque (c).  
The data does not allow an easy identification of different tissue types. Experts in anatomy can differentiate between 
the tissues because of their expertise and slightly preferred the quality of the phase tomography data. Here, they 
identified tissue structures such as smooth tissues, foamy cells, muscle walls and cholesterol. It has to be mentioned, 
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however, that the ring artifacts, which are much more prominent in the laboratory µCT data, create major peak 
broadening especially for the paraffin. The application of ring artifact corrections led to an inhomogeneous background 
in the laboratory µCT dataset not observed in the phase tomography data. 
For flow simulations in the blood vessel system, the lumen of the stenosed vessels has to be determined. Although 
the phase tomography provides better contrast for tissue differentiation, the SRµCT in the absorption contrast mode is 
much better suited for lumen segmentation. This surprising result is due to the nature of the artifacts present. In phase 
tomography, artifacts from the air bubbles led to such high differences in local ∆δ-values that the intensity-based 
segmentation by region-growing was impossible (cp. slice shown in Figure 4). The ring artifacts observed in laboratory 
µCT do not interfere with the segmentation procedure in the same manner. Therefore, the lumen from the data of the 
laboratory µCT was extracted from the 4.9 mm-long section of the artery (one slice given in Figure 4) using the region-
growing tool of the software VG Studio Max 2.1 (Volume Graphics, Heidelberg, Germany). The cross-sectional area 
was analyzed using computer code (MATLAB R2010b). The artery showed a minimal cross-section of 0.83 mm2 and a 
maximum cross-section of 5.60 mm2. This means the constriction corresponds to 85%. 
 
Figure 4. Comparison of phase tomography (left slice) and laboratory µCT (right slice) using a slice that contains an air 
bubble. The trapped air causes artifacts that prevent the segmentation of the vessel lumen in phase tomography data. 
3.4 Multi-modal imaging of a slice of an atherosclerotic human coronary artery 
The combination of modalities often yields additional information. Therefore, the combination of the tomography data 
with the histology might give additional insights into the tissue morphology. While tomography data contain X-ray 
absorption values and the real part of the refractive index for phase tomography, histology provides functional 
information depending on the stain applied. The disadvantage of histology, however, is the tremendous effort for serial 
sectioning and the limited spatial resolution in the third dimension, perpendicular to the slices. As a consequence 
researchers usually only prepare a limited number of histological slices. A 3D dataset of histological data is rarely 
generated. 
An H&E-stained histological slice was prepared from the atherosclerotic human coronary artery after the 
decalcification and nondestructive µCT data acquisition. This slice was registered with the datasets from absorption-
based SRµCT and phase tomography in the manner described above. The three related slices are displayed in Figure 5: 
the phase SRµCT data using red color, the absorption SRµCT-data with green color, and the histology slice using the 
blue color. The superposition of the slices given in the bottom right of Figure 5 supplies an image that highlights the 
relative contributions. 
The phase tomography slice, given in red, exhibits the biggest contrast between tissue types. The foamy cell region 
specified by the white circle in the RGB composite contains very low ∆δ values characterized using dark colors (almost 
black). In the phase SRµCT slice, the relatively high ∆δ values characterized by bright red originate from plaque. An air 
bubble enclosed in the paraffin created the striking artifact, i.e. the pair of well-localized high brightness streaks 
highlighted by the white arrow. 
Although the contrast between tissue types of the absorption SRµCT-slice (green color) is lower than in phase 
tomography, one recognizes the artifacts from the residual plaque. This observation indicates that the decalcification 
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procedure was incomplete. Such an incomplete plaque extraction, however, can be an advantage, since the location of 
plaque is identified without strong streak artifacts. 
The histological slice provides a higher spatial resolution than absorption SRµCT and phase tomography slices. 
Thus, the details of the anatomical microstructures are more easily visible. The microstructures are similar in the three 
slices. There are, however, some noteworthy observations. The foamy cells and fat correspond to the green part of the 
RGB image, since these tissue types show up as black or very dark areas in the phase tomography and histology. The 
plaque is bright pink, as it is brightest in the phase tomography. The phase tomography and histology contribute mainly 
to the muscle and vessel walls, so they appear violet. The artifacts from the air bubble in phase tomography are 
prominent. 
 
Figure 5: Comparison of phase tomography (red), absorption SRµCT (green) and histology (blue) techniques for visualizing 
tissue types in a stenosed human coronary artery. Arrows indicate sources of artifacts: air bubble (phase tomography) 
and residual plaque (absorption SRµCT). Bottom right: RGB composite image of the slices obtained from the three 
modalities. The white circle indicates the foamy cell region. The slice is situated just before a bifurcation. The 
protrusion in the bottom right of each image is the wall of the bifurcated artery. Dynamic range: The histogram of each 
image has been scaled to include only the tissue related peaks with values ranging from 0 to 255. 
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3.5 Arterial cross-section and extent of constriction 
Table 1 lists the cross-sectional areas of the lumens derived from tomography data of the PMMA model, the mouse aorta 
and the human atherosclerotic artery. The constriction was calculated from the ratio of the cross-sectional areas, i.e. 
minimal cross-section divided by the maximal cross-section. Assuming a circularly shaped vessel, one finds the radius at 
the maximum stenosis, which is more common in literature. 
Table 1. Morphological parameters of PMMA model, mouse, and atherosclerotic human vessels. 
Cross-section area [mm2] 
 
Average Maximum Minimum Std. dev. 
Maximum 
constriction [%] 
Minimum 
radius [mm] 
PMMA-model 
(healthy) 6.23 6.49 6.04 0.12 6.9 1.39 
PMMA-model 
(diseased) 3.52 6.43 1.17 1.78 81.8 0.61 
Mouse aorta 0.27 0.37 0.19 0.04 49.4 0.24 
Human artery 2.31 5.60 0.83 1.36 85.2 0.51 
4. DISCUSSION 
4.1 Morphology of mouse artery 
The mouse artery illustrated in Figure 2 show the challenge in the visualization of small specimens using grating-based 
phase tomography. During the grating interferometry experiment at the beamline W 2 the choice of the parameters was 
suboptimal. The third Talbot order, for example, leads to less sensitive images compared to the ninth Talbot order at the 
beamline ID 19. Due to beamtime restrictions, the experiment was carried out at a photon energy of 31 keV and not of 
23 keV. The reduction of the energy leads to a higher sensitivity of the experimental setup. Despite these challenges, the 
phase tomography at the W 2 beamline was sufficient to segment the lumen of the mouse artery, which was the imaging 
task of the experiment. It was impossible to obtain the same image quality with conventional absorption-contrast 
tomography. 
Although there is no constriction due to disease, the artery tapers to one end, giving rise to a maximum constriction 
of 49.4%. The average cross-sectional area of 0.27 mm2 (Table 1) corresponds to a 96% occlusion of a human coronary 
artery of 2.5 mm diameter. Due to these favorable dimensions, the mouse aorta could potentially be of use in flow 
studies or in vivo experiments for, e. g. testing the localized release of a marker from shear-sensitive nanocontainers. 
However, unlike the PMMA-model and human arteries, the mouse aorta is a continuous tube with no sudden change in 
cross-sectional area. The investigated section has a standard deviation of only 0.04 mm2, approximately 2% that of the 
PMMA model and human arteries. Additionally, we were unable to identify any calcified plaques. It is possible that the 
animal’s lifetime was insufficient to allow formation of calcified plaques, and that the disease model is not sufficiently 
representative of the pathology observed in human cases for these studies. This puts into question the usefulness of a 
mouse model for evaluating the role of shear stress in, e. g. targeted drug delivery in the human heart, cp. the recent 
paper of D. Ingber’s team [24]. Vortex formation and re-flow phenomena have been observed in flow simulations where 
the morphology has a major role in determining local shear stresses. It must be validated whether the aorta can be 
successfully connected to a flow system, whether the lack of plaque and diseased tissue could lead to a difference in drug 
metabolism, and (with flow simulations) whether such a smooth morphology is an appropriate model. 
4.2 Micro-morphology of atherosclerotic human coronary arteries 
Registered slices of a human coronary artery measured by laboratory µCT and phase tomography (Figures 3 and 4) were 
examined for their usefulness a) as modalities for identifying different tissues types, and b) for segmenting the non-
constricted cross-sectional area. The methods provide complementary results and the nature of the artifacts determined 
the limits of each dataset. 
Laboratory µCT showed ring artifacts, which did not interfere with the segmentation tool (VG Studio Max 2.1, 
Heidelberg, Germany) used to extract the non-constricted cross-sectional area. This imaging modality is a fast, 
convenient method for extracting data about the lumen morphology (Table 1). However, the artifacts from the highly 
Proc. of SPIE Vol. 8506  850609-9
38 2 Results
 
 
 
 
 
 
absorbing plaque obscured the morphology of the calcified regions and led to a broadening of the histogram compared to 
phase tomography (Figure 3). Coupled with the larger pixel size of 17.78 µm, it was impossible to identify all 
microstructures and therefore different tissue types. In contrast, phase tomography showed starburst artifacts caused by 
air bubbles in the paraffin formed during the embedding process (see Figures 4 and 5, phase tomography image, white 
arrow). This made segmentation of the lumen cross-sectional area impossible, but experts could identify different tissue 
types (foamy cells, calcifications, muscle etc.) and unstable plaques in phase tomography data by comparison with 
histology (Figure 5). 
To see whether identification of different tissue types could be achieved in absorption-based tomography, 
absorption SRµCT was also used as an imaging modality (Figure 5). Unfortunately, artifacts caused by the highly 
absorbing residual plaque (Figure 5, absorption SRµCT image, white arrow) also made it impossible for the experts to 
reliably identify different soft tissue types. 
Defining a critical stenosis is non trivial. The constriction is often defined in terms of reduction in diameter or cross-
sectional area [25-28], but can also be considered in terms of fractional or coronary flow reserve [29]. Accuracy of 
detection methods also influences results. For example, synchrotron radiation coronary angiography is able to detect 
diameters of down to 100 µm in beating hearts versus 400 µm in conventional angiography [25]. Reports of 99% 
stenosis by diameter in the literature are common [25], although often stenoses are only qualitatively characterized as 
‘severe’. Nielsen and co-workers define stenosis as >70% constriction and healthy as <30% constriction [30], whereas 
DeMaria et al. define significant stenosis as >50% [31]. However, such basic criteria may be misleading, since the 
hemodynamic effect also depends on the lesion length, blood viscosity and laminar flow characteristics that dictate flow 
velocity and wall shear stresses [32]. Other studies consider ≥75% stenoses by diameter as critical [33]. ST-elevation 
myocardial infarction (STEMI) occurs when a culprit lesion completely blocks a vessel. Therefore, 81.8% constriction 
by diameter as seen in this study is a reasonable model for targeting the culprit lesion whilst avoiding most other, non-
critical, stenoses. 
4.3 PMMA-model to reproduce the morphology of healthy and atherosclerotic human coronary arteries 
We were able to show that the PMMA-model presented similar morphology to a stenosed human coronary artery and 
was within a reasonable range according to the literature, and, therefore, appropriate to use in shear-release experiments 
as reported previously [4]. The maximum diameter of the healthy and diseased PMMA-model arteries is identical within 
error bars. The average diameter of the healthy artery PMMA model is 2.82 mm, within the values reported in vivo 
(normally 2 to 3 mm). The diseased artery PMMA-model exhibits a maximum occlusion of 81.8% cross-sectional area, 
corresponding to a minimum radius of 0.61 mm (Table 1). This is in accordance with constrictions reported in the latter 
stages of atherosclerosis based on measurements using, for example, angiography [34]. A critically stenosed artery 
(>80% stenosis) is of interest for studying release of a drug from a shear-stress sensitive nanocontainer [4]. The diseased 
model artery is within 1.8% of this value. Therefore, it is a reasonable approximation of a stenosed artery for further 
studies. 
The human artery and diseased PMMA-model have similar properties, with the human artery possessing an 85.2% 
maximum constriction by cross sectional area versus 81.8% in the diseased PMMA model. This corresponds to a 
minimum radius of 0.51 and 0.61 mm respectively. The human artery has generally 10% smaller dimensions, with a 
maximum cross-sectional area of 5.60 mm2 versus 6.27 mm2 for the PMMA models. However, it shows slightly less 
range in occlusion, illustrated by a smaller standard deviation in cross-sectional area (1.36 mm2 versus 1.78 mm2 in the 
diseased PMMA model). 
The PMMA model has a morphology that shows similar characteristics to the in vivo situation and is therefore very 
helpful for identification of nanocontainer formulations suitable for clinical studies, maybe even without any animal 
testing. 
5. CONCLUSIONS 
The PMMA model cross-sectional areas correspond well to the literature values in the case of both the healthy and 
diseased artery, with the latter falling in the severely stenosed category. Such a model is highly desirable for testing the 
suitability of shear stress sensitive nanocontainers as drug delivery vectors. 
The mouse aorta, although it is not stenosed to 80%, does present the cross-sectional area corresponding to a 96% 
constriction of a 2.5 mm diameter human coronary artery. This is slightly higher than desired for testing the suitability of 
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shear stress sensitive nanocontainers. Although the constriction is a model for a critically stenosed artery, such as in, e. g. 
ST-segment elevation MI (STEMI), its usefulness as a morphological model is limited, since it has a smooth 
morphology. 
Phase tomography gives high contrast images from which different tissues types can be identified by comparison 
with histology. However, artifacts from air bubbles make segmentation of the lumen unfeasible. This might be overcome 
by using PFA as a storage medium in place of paraffin. It is a useful tool for identifying the 3D morphology of tissue 
composition in decalcified human coronary arteries, when compared to histology as a reference. Laboratory µCT and 
absorption SRµCT do not provide as much resolution of different tissue types, but are more appropriate for the extraction 
of the artery lumen. Artifacts in phase tomography from air bubbles introduced in the paraffin embedding are more 
problematic in the segmentation procedure than the ring artifacts caused by residual plaque in laboratory µCT and 
absorption SRµCT. The various analysis tools provide a complementary analysis of tissue structure and morphology. A 
decalcified human coronary artery was found to present the desired morphology for testing the suitability of shear stress 
sensitive nanocontainers as drug delivery vectors. 
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2.3 Proof of principle: Mechano-sensitive
nano-containers for targeted drug delivery to
constricted vessels in the heart
The following highlighted article [73] is the first proof of principle that
mechano-sensitive nano-containers can be engineered to release their
contents selectively and rapidly at shear stresses such as those found in
critically constricted human coronary arteries. In vitro results using
a physiologically relevant healthy and critically constricted PMMA
model artery show the critically constricted model increases content
release from such nano-containers by 25% after only one pass.
Published in Nature Nanotechnology
Shear-stress sensitive lenticular vesicles for
targeted drug delivery
Margaret N. Holme1,2,3, Illya A. Fedotenko1, Daniel Abegg1, Jasmin Althaus2, Lucille Babel1,
France Favarger1, Renate Reiter4, Radu Tanasescu1, Pierre-Le´onard Zaffalon1, Andre´ Ziegler5,
Bert Mu¨ller2*, Till Saxer3* and Andreas Zumbuehl1*
Atherosclerosis results in the narrowing of arterial blood vessels and this causes significant changes in the endogenous
shear stress between healthy and constricted arteries. Nanocontainers that can release drugs locally with such rheological
changes can be very useful. Here, we show that vesicles made from an artificial 1,3-diaminophospholipid are stable under
static conditions but release their contents at elevated shear stress. These vesicles have a lenticular morphology, which
potentially leads to instabilities along their equator. Using a model cardiovascular system based on polymer tubes and an
external pump to represent shear stress in healthy and constricted vessels of the heart, we show that drugs preferentially
release from the vesicles in constricted vessels that have high shear stress.
L
iposomes are well-established drug delivery systems1 and are
vesicular in shape with an aqueous inner cavity. They are
formed spontaneously when amphiphatic phospholipids
contact water and align into mechanically stable bilayers. The
bilayer protects the aqueous cavity and its drug contents from
chemical and biological reactions before the vesicle arrives at the
target tissue1.
One way to trigger the release of drugs from liposomes is to
engineer liposomes that are sensitive to mechanical stress.
Conventional spherical liposomes are highly stable to mechanical
stress. Computer simulations have previously shown that lenticular
(or lentil-shaped) nanocontainers formulated from membranes
with large bending moduli are intrinsically more stable than their
spherical counterparts2. However, the relationship between vesicle
shape, stability to mechanical stress and atomic structure has not
been shown experimentally.
Non-spherical vesicles were described more than 30 years ago.
For example, unilamellar vesicles (diameter, 30 nm) formulated
from dipalmitoyl phosphatidyl choline (DPPC) demonstrate X-ray
patterns predicted for faceted particles in the form of truncated ico-
sahedra3. This morphology is probably induced by the hexagonal
packing of lipids in the gel state, but it is found only at the low
ionic strength of dilute salt solutions4. However, high curvature in
small unilamellar vesicles was found to lead to packing defects
that could be eliminated only through spontaneous fusion to form
spherical 70 nm unilamellar vesicles5,6. Other icosahedral vesicles
formed from a mixture of cationic and anionic surfactants also
required salt-free conditions to form7,8, and these vesicles would dis-
sociate at the isotonic sodium chloride concentrations needed for
drug delivery.
To make non-spherical vesicles, lipid membranes need to have
large bending moduli (that is, exist in a gel phase)2. This feature
can be introduced by exchanging the ester bonds of natural phos-
pholipids for artificial amides that stabilize the interfacial region
through hydrogen bonds. So far, the introduction of amides9–11
or carbamates12 has been inspired by the design of serum-stable,
phospholipase A-resistant lipids that have potential anti-HIV and
anticancer properties. In these approaches, the amido fatty-acid
tails replace the esters at the sn-1, sn-2 or both positions. It was
not until recently that symmetrical insertion of carbohydrate fatty
amides at the 1- and 3-positions and a residual phosphate ester at
the 2-position was reported13,14. The shear-stress resistance of the
amido-phospholipids is unknown but some data suggest that
additional hydrogen bonding may make the vesicles more stable
and less prone to drug release11,12.
Based on these considerations, we hypothesized that endogenous
shear stress in critically constricted blood vessels (such as those
found in atherosclerotic patients) might lead to transient pore for-
mation in lenticular vesicles. Our results show that the lenticular
vesicles preferentially release drugs in a model cardiovascular
system, suggesting that such vesicles may potentially be used to
treat cardiovascular diseases in a targeted manner.
A new diamidophosphocholine forms faceted vesicles
A recent publication reported the synthesis of amide-bearing phos-
phoethanolamines13. As most of these molecules are insoluble in
organic solvents, the terminal amines were quaternized, which
greatly improved the solubility. The synthesis of amide-bearing
1,3-dipalmitamidopropan-2-yl 2-(trimethylammonio)ethyl phos-
phate (Pad–PC–Pad, 1) (Fig. 1, see ref. 13 for nomenclature) was
achieved by exhaustive methylation with dimethylsulphate from
the corresponding ethanolamine precursor (see Methods and
Supplementary Section S1.1). The final compound was purified by
silica gel and gel permeation column chromatography.
The artificial phospholipid Pad–PC–Pad contains two amide
bonds, intended to stabilize the polar region of the membrane
through additional hydrogen bonds. Indeed, a shorter 1,2-dimyristami-
dopropan-2-yl 3-(trimethylammonio)ethyl phosphate Mad–Mad–PC
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phospholipid with two C 14:0 amido chains in a 1,2-position
did show reduced membrane fluidity at the polar interface11.
The Pad–PC–Pad substitution at both the 1- and 3-positions
should therefore yield amide groups with better steric align-
ment for directionally dependent hydrogen-bond formation in
the polar hydrated region. This 1,3-configuration renders
the lipid insensitive to metabolization by phospholipase A2
(Supplementary Fig. S1).
Pad–PC–Padwas comparedwithN-palmitoyl-D-erythro-sphingosyl-
phosphorylcholine (16:0 SM, 2), a natural lipid containing one amide
bond, and to dipalmitoylphosphatidylcholine (3), which contains no
amides (Fig. 1). Differential scanning calorimetry (DSC) measure-
ments of 100 nm unilamellar vesicles prepared by the extrusion
method (LUVET100) in buffer showed that Pad–PC–Pad has a
phase transition temperature Tm of 35 8C (DH¼ 7,260 cal mol21;
t1/2¼ 3.2 K; Supplementary Fig. S2), which is lower than
the Tm of 16:0 SM (39.2 8C, DH¼ 7,586 cal mol21; t1/2¼ 2.5 K)
and DPPC (40.9 8C, DH¼ 6,001 cal mol21; t1/2¼ 1.9 K)15,16.
Analogously, earlier literature on Mad–Mad–PC (Tm¼ 18 8C)
reported a comparable 5 K decrease in Tm compared to the natural
dimyristoyl phosphatidylcholine (Tm¼ 23 8C)11. In contrast, redu-
cing the N-acyl chain length by two carbons results in a much
larger change in Tm (13–25 K, ref. 17), suggesting that changes in
the acyl chain length contribute more to the chain melting
temperature than a shift of the substitution pattern from 1,2 to 1,3
in the polar interface18.
To visualize the morphology of the liposomes with fluorescence
microscopy, we prepared giant unilamellar vesicles (GUVs) by the
electroformation method19,20. The fluorescent lipid lissamine rhoda-
mine DOPE (rho-DOPE) was used as fluorescent marker at 1 mol%
of the total lipid content. The dye is expected to accumulate prefer-
entially in the fluid membrane phase and will not penetrate into
solid domains.
Several of the observed vesicles were faceted and differed distinc-
tively from the spherical geometry of conventional vesicles.
Figure 2a shows an example of a GUV resembling a higher-order
polyhedron with a co-existence of liquid-ordered and fluid
domains (Supplementary Fig. S2). The fluorescent probe rho-
DOPE is not observed in areas of flat faceted liquid-ordered
domains, but is sequestered into the curved fluid domains in the
middle and edges of these facets. The addition of cholesterol
(Fig. 2b) results in a more fluid membrane and spherical vesicles.
Theory2 predicts the accumulation of the dye in the fluid-phase
region of high curvature. As the flat facets are connected by bound-
aries of higher curvature, one would also expect to find fluorescent
dye molecules in this region, as confirmed by our experiments.
Cryo-transmission electron microscopy (TEM) was carried out
for LUVET100 as described previously
21. A snapshot of the vesicle
morphology shows that, in this size regime, lenticular rather than
spherical or faceted vesicles are formed (Fig. 2c,d). These
LUVET100 were initially prepared above the Tm of Pad–PC–Pad.
After cooling to 20 8C, they could relax to non-spherical shapes
because of the propensity of Pad–PC–Pad to form flat membranes.
The lenticular morphology is regarded as an intermediate state of
minimized energy between a spherical vesicle and a flat surface2.
Non-spherical vesicles demonstrate a lower encapsulated volume
per surface area than a sphere with the same surface. It is therefore
expected that lenticular vesicles will encapsulate less material per
surface area than spherical vesicles. However, calculations showed
the encapsulation efficiency of a representative Pad–PC–Pad lenti-
cular vesicle selected from a cryo-TEM image was only 3% lower
than a spherical vesicle of the same surface area (Supplementary
Fig. S3). This was corroborated experimentally by measuring the
total entrapped volume of carboxyfluorescein in vesicles formulated
from a known total concentration of Pad–PC–Pad (Supplementary
Section S5). We therefore conclude that the loss in encapsulation
efficiency is negligible.
The equators of lenticular vesicles probably represent
breaking points, suggesting that Pad–PC–Pad vesicles might
exhibit special properties, that is, leaking under mechanical stress.
First preliminary cytotoxicity and complement activation tests
(Supplementary Fig. S4 and Table S1) revealed no negative
effects from the non-spherical form factor, as were reported for
doxorubicin-loaded liposomes22.
Pad–PC–Pad vesicles are mechanosensitive
To test the mechanical properties of the corresponding nanocontai-
ners, we prepared LUVET100 (1–2 orders of magnitude smaller than
GUVs) of artificial and natural phospholipids 1 to 5. We hydrated a
thin film of lipids and extruded the multilamellar vesicles through a
100-nm-pore filter membrane to produce uniform LUVET100
(ref. 23). The liposomes contained 5(6)-carboxyfluorescein at a
self-quenching concentration during encapsulation. When the dye
is released from the liposome into the medium it dilutes, leading
to fluorescence dequenching, and is therefore detectable using fluor-
escence spectroscopy24.
Figure 3a shows the stability of vesicles that were left untouched
on the laboratory bench for the indicated periods of time
(Supplementary Fig. S5). At 25 8C, lipids 1 to 3, which were in
the gel state25–27, released less than 12% of their cargo over one
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Figure 1 | Chemical structures of phospholipids. 1, Pad–PC–Pad, an artificial
phospholipid containing two amide bonds at positions 1 and 3 of the original
glycerol backbone. 2, N-palmitoyl-D-erythro-sphingosylphosphorylcholine
(16:0 SM), containing one amide bond. 3, DPPC. 4, 1-Palmitoyl-2-oleoyl-sn-
glycero-3-phosphocholine (POPC), the dominant component of EggPC,
contains no amide bonds, but ester bonds instead. 5, Pad–Pad–PC,
the asymmetric variant of 1.
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week, typically at a rate of ,1% per day. In contrast, lipid 4, which
was in the liquid state, did release cargo over time. It remains to be
seen to what extent lipid chain interdigitation adds to the stability of
the described bilayers. However, neither 16:0 SM (2) nor DPPC (3)
shows interdigitation28.
The vesicle formulations were then placed into a glass vial and
shaken on a vortex at 2,500 r.p.m. at 25 8C for up to 60 s. Figure 3b
shows that neither 16:0 SM (2) nor DPPC (3) vesicles release their
carboxyfluorescein cargo. In contrast, Pad–PC–Pad (1) vesicles
release their cargo to a significant extent. Together with the data in
Fig. 3a, it is obvious that Pad–PC–Pad demonstrates a characteristic
behaviour in which the vesicles are perfectly stable at rest but
release their contents on shaking (leakage was induced even when
agitating the vial in the experimenter’s hand). We postulate
that these vesicles respond to the applied shear forces with
transient leakage, similar to the shear-induced release from L-a-phos-
phatidylcholine (EggPC) vesicles29,30. Furthermore, the alignment of
amides in the 1,3-diamidophospholipid Pad–PC–Pad is of para-
mount importance. We synthesized the corresponding asymmetric
1,2-diamidophospholipid Pad–Pad–PC (5, Supplementary Sections
S1.2–1.4), and vesicles formulated from this lipid demonstrated a sig-
nificantly reduced shear sensitivity (Fig. 3b).
One can define three classes of vesicles with distinct release prop-
erties. First, natural vesicles in the liquid state (EggPC) show
spontaneous leakage that is accelerated by shear stress (Fig. 3a–c,
4). Second, natural vesicles in the gel state (16:0 SM (2) and
DPPC (3)) show no spontaneous release and are insensitive to
mechanostimulation. Here, we present a third class of vesicles
made from the artificial Pad–PC–Pad (1). In the gel state they
show no spontaneous release, but they are mechanosensitive.
In the liquid state, immediate total spontaneous release of vesicle
cargo is observed (Fig. 3c). Both release patterns are beneficial for
drug delivery.
Figure 3d shows that the shear-induced leakage from Pad–PC–
Pad vesicles at room temperature is inversely proportional to the
concentration of liposomes in suspension. We find that the vesicles
do not fuse but instead aggregate within 5 s, especially above a
vesicle concentration of 54 mM, reducing the probability of vesicle
leakage (Supplementary Fig. S6). Under shear stress, these aggre-
gates break down to their 100 nm vesicle components (Fig. 6c,d).
Biphasic nature of Pad–PC–Pad monolayers
Monolayer studies give a first approximation of the biophysical
characteristics of a phospholipid. Pad–PC–Pad demonstrates a
sharp inflection at the phase transition from the gaseous analogue
to the liquid expanded phase (Fig. 4a), similar to the reported
pressure–area isotherms of N-myristoylethanolamine, where the
importance of hydrogen bonding has been emphasized31. This
a b
200 nm
5 µm10 µm
d
200 nm
c
Figure 2 | Confocal micrographs of GUVs and cryo-TEM micrographs of LUVET100s formulated from Pad–PC–Pad. a, GUVs made from 100% Pad–PC–Pad
(doped with rho-DOPE) have various shapes, including this polyhedron (see Supplementary Movie). b, Adding 30 mol% cholesterol to the membrane is
expected to induce a more fluid membrane state, which is corroborated by the spherical morphology of the GUVs and homogeneous distribution of
rho-DOPE. Both measurements were made at 25 8C. c, Cryo-TEM of LUVET100 formulated from Pad–PC–Pad, seen from the top and from an angle of 458.
d, The lenticular morphology of the 100 nm vesicles is clearly visible. An example of this lenticular shape, with two spherical segments joined by a
discontinuity around the diameter, is highlighted. Also, straight edges contrast with the round morphology typically found in vesicles formulated from natural
phospholipids such as EggPC.
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phase transition is followed by a plateau region, characteristic of a
liquid expanded/liquid condensed two-phase coexistence32 and
the onset of two-dimensional crystallization33. The minimal area
per molecule was approximated by extrapolating the pressure–area
isotherm at its highest slope to zero surface pressure34. This resulted
in a value of 49 Å2 for DPPC, 56 Å2 for Pad–PC–Pad and
59 Å2 for 16:0 SM (Supplementary Fig. S7), in agreement with
literature values35–37.
Brewster-angle microscopy confirmed the coexistence of solid
crystallization domains present in the liquid phase (Fig. 4b) of
single-component Pad–PC–Pad monolayers. The microstructures
observed resemble the fractal or dendritic domains formed by
pure sphingomyelin37. However, the reported domains for sphingo-
myelin stop growing at 12 mN m21 and 40–50 mm, at equilibrium
between the forces of line tension and long-range dipole–dipole
repulsion38. In the present experiments, domains of Pad–PC–Pad
keep growing and fusing, similar to DMPE domains39–41. This evi-
dence for coexisting domains was corroborated by monolayer
fluorescent microscopy experiments using 1 mol% of a fluorescent
phospholipid (Fig. 4c).
The fact that Pad–PC–Pad crystallizes at higher surface pressure
and below Tm hints at a heightened bending modulus at room
Time (s)
Fl
uo
re
sc
en
ce
 re
le
as
e 
(%
)
10 20 30 600
20
40
60
Time (s)
Fl
uo
re
sc
en
ce
 re
le
as
e 
(%
)
2:1
1:1
1:2
1:4
Dilution
c d
0 20 40 60
0
40
80
0 2 4 6
0
40
80
Time (days)
Fl
uo
re
sc
en
ce
 re
le
as
e 
(%
)
0 20 40 60
0
40
80
Time (s)
Fl
uo
re
sc
en
ce
 re
le
as
e 
(%
)
a b
1
2
3
4
5
1 (4 °C)
1 (25 °C)
1 (37 °C)
4 (4 °C)
4 (25 °C)
4 (37 °C)
1
2
3
4
5
Figure 3 | Release of carboxyfluorescein from vesicles made of phospholipids 1 to 5. a, Spontaneous release of vesicle cargo on prolonged storage at 25 8C.
b, Release of vesicle cargo on shaking the vial on a vortex shaker at 25 8C. It is apparent that vesicles prepared from EggPC (4) release their cargo in either
situation, whereas Pad–PC–Pad (1) vesicles only release cargo when shaken. c, Effect of temperature on vesicle cargo release on shaking on a vortex shaker.
d, Effect of Pad–PC–Pad vesicle suspension dilution (stock phosphoplipid concentration, 54mM) on vesicle cargo release on shaking on a vortex shaker at
room temperature. Release increases with time and dilution. Error bars are standard deviations of triplicates.
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Figure 4 | Monolayer studies of Pad–PC–Pad. a, Pressure–area isotherms for the lipids studied at 20 8C. A clear inflection point is visible for Pad–PC–Pad but
not for the other lipids. b,c, Micrographs showing the ramified morphology of crystallized Pad–PC–Pad islands in a liquid Pad–PC–Pad matrix. The presence of
crystallized regions is clearly visible at .20 mN m21 and 20 8C. The formation of crystals in the fluid phase shows the coexistence of a biphasic system.
Snapshot (b) of a Brewster-angle micrograph at 23 mN m21. Crystallites merge and form more complex forms within minutes40,41. Fluorescent microscopy
(c) of a Pad–PC–Pad monolayer (doped with 1 mol% of the fluorescent probe 1-palmitoyl-2-{6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl}-sn-glycero-
3-phosphocholine) at 23 mNm21 and 20 8C.
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temperature leading to faceted vesicles. The GUV experiments
(Fig. 2) essentially corroborate this explanation of the predicted
non-spherical morphologies2.
Shear force-based drug delivery
We went on to test whether lenticular vesicles might have potential
in shear-induced drug delivery to constricted arteries for the treat-
ment of atherosclerosis, a generalized inflammatory process of the
artery wall42. Lipid deposition on the artery wall begins at the age
of 25 years in humans, with the blood vessels slowly becoming
increasingly narrow until, finally, some plaques can occupy up to
90% of the lumen43, with myocardial infarction occurring with
stenoses well above 70% (ref. 44). Such a vessel narrowing
fundamentally changes the blood flow pattern: healthy coronary
arteries show average shear stresses of 1.5 Pa, and this value
rises to 7–10 Pa, or even well above 10 Pa, in constricted vessels45.
So far, there has been no report of shear stress-induced drug
delivery. However, fundamental rheological studies have shown
that shearing of EggPC vesicles is concomitant with an increased
efflux of entrapped Ca2þ compared with the slower release of
entrapped ions from non-sheared vesicles29,30,46. Similarly, the
release of a fluorescent dye is also increased by shearing of small
and large unilamellar vesicles made from EggPC and Brij 76 (deca-
ethylene glycol octadecyl ether, known as Brij S10)29.
To assess the feasibility of drug release from a vesicle through
shearing, carboxyfluorescein-loaded vesicles of varying formu-
lations were subjected to in vitro shear conditions in haemodynamic
flow conditions (Fig. 5a). To simulate physiological conditions, a
model cardiovascular system was used that consisted of healthy
and constricted lumens formed from poly(methyl methacrylate)
(Fig. 5b). Both artery models were formed from tubes with an
inlet diameter of 2.5 mm, one of which was provided with constric-
tions of up to 75% cross-sectional area along a 2.5 cm segment. The
shear stress in each arterial model was estimated from two-dimen-
sional images, and was found to be40 Pa in the constricted model
and 2 Pa in the healthy model. These values are within reported
physiological ranges (Supplementary Fig. S8).
An extracorporeal circulation pump was used to simulate the
heart. This pump is a validated medical device for use in coronary
bypass and aortic valve replacement surgery and was chosen
because of its reputed low intrinsic shear stress47,48. Flexible tubes
with an inner diameter of 10 mm connected the pressure gauge,
flow reader and temperature bath. The pressure and flow rate in
the entire in vitro system were controlled by regulating the pump
speed. Pressures, flow rates, osmolarity and temperature were strictly
maintained within physiological ranges (details below). The model
was kept intentionally simple to investigate the contributing
effects of the endogenous shear stresses in healthy and constricted
models, providing a proof-of-concept for the hypothesis.
The vesicle suspension was first diluted to a lipid concentration
of 15 mM in external buffer. Both the buffer and carboxyfluorescein
media were adjusted to pH 7.4 to avoid pH-gradient-induced car-
boxyfluorescein leakage49. The diluted suspension was then loaded
into the in vitro pump set-up with either the healthy or the
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constricted poly(methyl methacrylate) artery model connected.
During the experiments, flow rates of 700 ml min21 (healthy)
or 350 ml min21 (constricted artery model) were used, the pressure
was 60 mmHg and the buffer temperature was 37 8C for long-circu-
lating and 34 8C for single-pass experiments (Supplementary
Fig. S9). Osmolarity was constant at 308 mOsm. Fluorescence
release from vesicles was analysed by a fluorescence 96-well-plate
reader. The error corresponds to the standard deviation of
the triplicates.
To assess shear-induced release after a single pass through the
pump, the vesicle suspension was pumped through the model
artery and collected directly after the first pass (Fig. 5b). To assess
release as a function of number of circulations, a closed loop was
built. Aliquots of the circulating vesicle suspension were collected
after 5, 10, 15 and 20 min. Flow was stopped for aliquot extraction
using a syringe by closing the tap in the loop. With each aliquot
extraction, an equivalent amount of buffer was injected.
Vesicle formulations reported in previous rheology studies were
adapted and optimized28. The surfactant Brij S10 was admixed to
EggPC at low concentrations (Fig. 5c,d). The optimized Brij S10
concentration led to high differences in the fluorescence release in
the healthy and constricted lumens. This occurred at a concen-
tration of 0.6 mol%, with 17+1% of the entrapped dye being
released after 40 passes through the constricted model but only
3.0+0.8% release after passing through the healthy artery
(Supplementary Fig. S10). At Brij S10 concentrations of 0 and 1%
there was no appreciable difference in the release in the constricted
and healthy arteries, so the shear stress-induced release is unspecific.
Compared with the EggPC/Brij S10 vesicles, vesicles consisting
entirely of Pad–PC–Pad demonstrated an even clearer distinction
between release in the healthy and constricted vessel models.
A low level of leakage occurred before treatment (19.0+2.7%;
release resulting from the formulation procedure and handling),
but, after only one pass, a total leakage of 45.5+11.0% was observed
in the healthy artery model and 70.0+2.3% in the constricted
model (Fig. 6a,b).
Pad–PC–Pad was then admixed with EggPC to mitigate the
release effect. Up to concentrations of 75% Pad–PC–Pad, the back-
ground fluorescence increased, but there is no statistically significant
increase in release after one pass in either the healthy or constricted
model (Fig. 6a, Supplementary Fig. S11). Therefore, one has to con-
clude that these formulations become unstable, or leaky, with an
increase in Pad–PC–Pad concentration, but do not significantly
increase their susceptibility to shear-induced release. The pure
Pad–PC–Pad vesicles, however, are susceptible to shear-induced
release, and show an appreciable preference for release in the
high-shear-stress constricted-artery model (Fig. 6b). In contrast,
in all formulations containing EggPC, shear-induced release
was always ,10% after one pass, and increases with concentration
of Pad–PC–Pad.
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Steinberg and co-workers50 reported that isolated vesicles tank-
tread and tumble in shear flow, but do not form pores. However,
we postulate that the investigated Pad–PC–Pad vesicles may
exhibit different behaviour under shear stress, given their smaller
size and the secondary effects of vesicle collisions. Dynamic light
scattering (DLS) investigation of Pad–PC–Pad vesicles established
whether the vesicles were destroyed or simply deformed during
release of their payload. Samples were measured after one pass
and continuous circulation through the healthy- and constricted-
artery models (Fig. 6c,d). Freshly prepared vesicles (not shown)
showed no aggregates in the range 1–10 mm; however, even in the
control measurement (constituting vesicles left on the bench for
the duration of the experiment), vesicle aggregation was observed
(Fig. 6c,d). After exposure to low shear environments—for
example, one pass through the healthy artery (Fig. 6c)—the peak
at 1 mm increased, indicating vesicle aggregation or fusion accord-
ing to literature precedence29. However, after being subject to
higher shear stresses (Fig. 6d) or repeated circulation (Fig. 6c; 10–
20 min), these aggregates were broken into LUVET100. The area
under each curve remained constant, suggesting there was no sig-
nificant loss in overall vesicle concentration. Furthermore, TEM
showed that Pad–PC–Pad nanocontainers are prone to aggregation
and not fusion (Supplementary Fig. S6). Aggregation and separation
is therefore a likely explanation for the changes in mean size
measured. These findings show that the release mechanism is
most probably due to shear-induced transient pore formation at
high shear rates, and not shear-induced destruction of the vesicles.
Conclusions
In conclusion, we have shown that the specially designed lenticular
Pad–PC–Pad phospholipid vesicles could shift current paradigms of
drug release from biochemical to endogenous mechanical triggers.
The lenticular shape of the liposomes leads to preferential breaking
points along the equator that make them sensitive to increased shear
stresses. Furthermore, we have shown, using a model cardiovascular
system, that the Pad–PC–Pad vesicles preferentially release drugs in
areas of high shear stress such as those that mimic constricted blood
vessels in heart attack patients. If successfully applied, this could
eliminate the side effects arising from systemic injection of drugs.
The release of a fluorophore from Pad–PC–Pad vesicles is an
order of magnitude higher than that of its natural counterparts,
such as EggPC. This observation might lead to significant inno-
vations in targeted drug delivery using purely physical triggers.
Methods
Synthesis of Pad–PC–Pad (1). Pad–PE–Pad (non-methylated
phosphoethanolamine, 1 g, 1.45 mmol) was dissolved in 100 ml of methanol.
Dimethyl sulphate (1 ml, 1.33 g, 10.5 mmol) was added and the mixture was
warmed to 40 8C, then a solution of 1.45 g (10.5 mmol) potassium carbonate in
20 ml water was added over 1 min. The mixture was vigorously stirred for 30 min
then cooled to 20 8C. The solvent was removed under reduced pressure. The
solid was then purified on a silica gel column (75% CH2Cl2, 22% MeOH, 3% aq.
NH4OH (25%)), yielding 0.56 g of the product (0.81 mmol, 53%) (Supplementary
Section S1.1).
Production of vesicles and loading with active compounds. All compounds were
purchased from Sigma-Aldrich or Avanti Polar Lipids and used without further
purification unless otherwise stated. Liposome formulation was based on the
techniques described by Olson et al.23.
LUVET100 were prepared as follows. Lipid (30 mmol; for example, egg yolk
phosphatidylcholine (EggPC, Avanti Polar Lipids), Pad–PC–Pad (1) or a
combination of lipids) was weighed into a 25 ml round-bottomed flask and
dissolved in 1 ml chloroform. Any required additive was added at this point. After
evaporation to dryness, the film was dried for 12 h under high vacuum. Internal
buffer (1 ml, 50 mM 5(6)-carboxyfluorescein, 10 mM HEPES buffer (AppliChem),
10 mM NaCl dissolved in pure water, pH 7.4 (NaOH)) was added to the flask to
hydrate the film for 30 min. The suspension was sequentially frozen (liquid nitrogen
bath) and melted (water bath, 40–65 8C, depending on constituent lipid Tm) five
times, then extruded 11 times using a mini-extruder (Avanti Polar Lipids) and a
track-etched filter (100 nm, Whatman). Purification by size exclusion
chromatography (1.5× 20 cm Sephadex G-50 column) in external buffer (107 mM
NaCl, 10 mM HEPES dissolved in ultrapure water, pH 7.4 (NaOH)) afforded the
pure 5(6)-carboxyfluorescein-loaded vesicles. Vesicles were stored at 5 8C in the
dark until use. All experiments were conducted within 24 h of vesicle formulation.
GUVs were preared as follows. Pad–PC–Pad (1, 0.5 mg) was dissolved in 1 ml
CHCl3. To this, 10 ml of Liss-Rho-DPPE solution (0.25 mg of lipid in 1 ml CHCl3)
was added. ITO-coated glass plates were washed with water and EtOH, then CHCl3.
A volume of 20 ml of the lipid solution was deposited on the conductive face of the
plate. CHCl3 was evaporated in the oven (room temperature) for 1 h at reduced
pressure. A second ITO slide was put on top of the first using Vitrex as sealant.
The void was filled with iso-osmolar sucrose solution (224 mOs). Vesicles were then
grown for 2 h at 55 8C at 1 V and 10 Hz.
An ‘observation chamber’ was made from two glass microscopy slides that were
washed with water and EtOH. A square of parafilm was laid out between the two
plates and melted at 100 8C. The chamber was washed with casein solution
(2 mg ml21) and left to dry for 15 min. The solution was then replaced with HEPES
buffer of the same osmolarity (200 mOs) as the sucrose solution. A volume of 10 ml
of lipid solution was added and the chamber was sealed with varnish.
Spontaneous release and vortex release. LUVET100 were prepared using 2 mg
Pad–PC–Pad (1), DPPC (AvantiLipids) or N-palmitoyl sphingomyelin
(AvantiLipids) in 0.5 ml of carboxyfluorescein buffer (10 mM HEPES, NaOH pH
7.4, 10 mM NaCl, 50 mM carboxyfluorescein). The extrusion procedure and size
exclusion chromatography purification are described above. The purified liposomal
suspension was diluted to 100 ml with a second buffer (10 mM HEPES, NaOH pH
7.4, 10 mM NaCl). Five 3 ml aliquots were filled into 20 ml vials with polystyrene
caps and vortexed for a discrete amount of time (0, 5, 10, 20 and 60 s) at 2,500 r.p.m.
Release of contents was measured by a plate reader at wavelengths of 492 nm
(excitation) and 517 nm (emission).
Spontaneous release was measured daily over 6 days for each sample. As a
control for maximum dye release, a second sample of the liposomal suspension was
mixed with a small volume of detergent (Triton-X100).
Influence of vesicle concentration on the release by vortex. LUVET100 were
formulated using the procedure described above (2 mg of Pad–PC–Pad (1) in 0.5 ml
of carboxyfluorescein buffer (10 mM HEPES, NaOH pH 7.4, 10 mM NaCl, 50 mM
carboxyfluorescein)). The purified suspension was diluted to 50 ml with a second
buffer (10 mM HEPES, NaOH pH 7.4, 10 mM NaCl). The suspension was then
diluted (2:1, 1:1, 1:0.5, 1:0.25). Five 3 ml aliquots were filled into 20 ml vials with
polystyrene caps and vortexed for a discrete amount of time (0, 5, 10, 20 and 60 s) at
2,500 r.p.m. Release of the content was measured by a plate reader at wavelengths of
492 nm (excitation) and 517 nm (emission).
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The extracorporeal circulation pump (Medtronic Bio-Medicus 540 Bio-Console) was a gift from the 
hemodynamic group of the intensive care unit of the University Hospitals of Geneva and is greatly 
acknowledged. The heating unit (Medtronic BioCal 370) was a generous gift of BIT Medical and is 
greatly acknowledged. 
 
1. Synthesis of phospholipids and their characterisation 
Starting compounds and solvents were purchased from Sigma-Aldrich/Fluka or Acros and were 
used without further purification. The precursor Pad-PE-Pad and its homologues were synthesised 
using the procedures from Fedotenko et al.1. 
Column chromatographic separation was carried out using 230-400 mesh silica gel. TLC plates 
were developed either with potassium permanganate mixture (1 g of KMnO4, 2 g of Na2CO3, 
100 mL of H2O) or ethanolic solution of phosphomolybdic acid. 1H, 13C and 31P NMR spectra were 
recorded (as indicated) on either a Bruker 300 MHz or 400 MHz spectrometer and are reported as 
chemical shifts (δ) in ppm relative to TMS (δ = 0). Spin multiplicities are reported as a singlet (s) or 
triplet (t) with coupling constants (J) given in Hz, or multiplet (m). Electron-spray ionisation mass 
spectroscopy (ESI-MS) for the characterisation of compounds was performed on a ESI API 150EX 
and are reported as mass-per-charge ratio. IR spectra were recorded on a Perkin Elmer Spectrum 
One FT-IR spectrometer (ATR, Golden Gate). The melting points are uncorrected. For the 
experiments with vortex we used an IKA Vortex Genius 3. 
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 2 
Monolayers were measured on a Langmuir Film Balance (Riegler & Kierstein, Germany). Pressure- 
area isotherms were calculated using the following equation2: 
κT = (-1/A)(∂A/∂π)T 
Where κT is the 2D isothermal lateral compressibility; A is the surface area per molecule and π is 
the surface pressure. 
BAM was recorded on a Multiskop (Optrel). The fluorescent microscope was made by Riegler & 
Kierstein, Germany. DSC thermograms were recorded on a Microcal VP-DSC (Microcal, 
Northampton, UK). The artificial blood-vessel model was made by Elastrat Sàrl, Switzerland. The 
extracorporeal circulation pump was a gift from Medtronic Bio-Pump, Bio Console 540, Medtronic, 
Switzerland. 
Cryo-TEM was carried out for LUVET100 using a Tecnai F20 TEM (FEI, USA) at the Electron 
Microscopy Center, ETH Zurich. 
1.1 Characterisation of 1,3-dipalmitamidopropan-2-yl 2-(trimethylammonio)ethyl phosphate 
(Pad-PC-Pad, 1) 
Rf= 0.32 (75% CH2Cl2, 22% MeOH, 3% aq. NH4OH (25%)). 
1H NMR (400 MHz, CDCl3) δ 7.58 (s, 2H), 4.39 (s, 2H), 4.12 (s, 1H), 3.89 (s, 2H), 3.48 (s, 2H), 3.36 
(s, 9H), 3.25 – 3.02 (m, 2H), 2.18 (t, J = 7.3 Hz, 4H), 1.56 (s, 4H), 1.24 (s, 48H), 0.87 (t, J = 6.7 Hz, 
6H). 
13C NMR (101 MHz, CDCl3) δ 174.7 (C=O), 72.2 (CH), 66.7, 59.6, 54.7(CH3s at the headgroup), 
41.0, 36.9, 32.1, 29.89, 29.84, 29.72, 29.70, 29.59, 26.2, 22.9, 14.3 (CH3s of the tails). 
31P NMR (121 MHz, CDCl3) δ 2.97. 
LRMS (ESI+)m/z calcd for C40H83N3O6P [M+H]+ 732.6, found 732.7. 
FTIR (cm-1): 3285, 2917, 2850, 1651, 1545, 1468, 1239, 1088, 1058, 967, 720. 
mp 203°C. 
Zeta Potential HEPES buffer: -5.46 mV ± 0.4281 mV Pad-PC-Pad (1): -4.04 mV ± 0.334 mV 
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1.2 (rac) tert-Butyl (2-((amino((1,2-dibromooropropan-3-yl)oxy)phosphoryl)oxy)ethyl)-
carbamate (6) 
 
0.514 mL (1.09 g, 5 mmol) of rac-1,2-dibromopropanol 
were added to 0.458 mL POCl3  (0.770 g, 5 mmol) and 
1.39 mL NEt3 (1.01 g, 10 mmol) in 50 mL of dry CH2Cl2 
and the resulting solution was stirred for 2 h. To this was added 0.810 g (5 mmol) of Boc-protected 
ethanolamine.1 The mixture was stirred for 4 h, after that solvent was removed under reduced 
pressure, and the product was purified over a silica gel column (2% MeOH-CH2Cl2) to give 6 as a 
white solid (0.52 g, 1.22 mmol, 24%). 
Rf=0.5 (EtOAc) 
1H NMR (500 MHz, CDCl3) δ 5.30 – 5.04 (m, 1H), 4.48 – 4.35 (m, 2H), 4.35 – 4.24 (m, 1H), 4.23 – 
3.98 (m, 2H), 3.87 – 3.71 (m, 2H), 3.53 – 3.21 (m, 4H), 1.44 (s, 9H). 
13C NMR (126 MHz, CDCl3) δ 156.0, 118.9, 79.7, 69.5, 69.5, 67.0, 67.0, 66.91, 66.87, 66.3, 48.0, 
48.0, 47.9, 40.9, 32.1, 32.0, 28.4. 
31P NMR (121 MHz, CDCl3) δ 13.3. 
HRMS (ESI+) C10H22Br2N2O5P m/z calcd [M+H]+ 438.9627 obs. 438.9626 
FTIR (cm-1): 3279, 2977, 1671, 1518, 1238, 1166, 1029, 858, 780 
Mp=70-75°C 
                                            
1I. A. Fedotenko; P. L Zaffalon; Favarger, F.; Zumbuehl, A. Tetrahedron Lett.2010, 51, 
5382–5384. 
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1.3 rac-tert-butyl (2-((amino(2,3-dipalmitamidopropoxy)phosphoryl)oxy)ethyl)carbamate 
(Pad-Pad-PEBoc) (7) 
520 mg (1.22 mmol) of dibromide (6) and 199 mg (3.05 
mmol) of NaN3 were dissolved in dry DMF and stirred at 
100 °C for 10 h. After that DMF was removed in vacuo. 
Any residual DMF was removed by co-evaporation with MeOH under reduced pressure. The dry 
crude product was separated over a silica gel column (5% MeOH-CH2Cl2) to give 220 mg of an oil, 
which crystallized upon standing. It was further dissolved in 40 mL of MeOH, and a catalytic 
amount of 10 weight% Pd/C (15 mg, 1 mol%) was added and H2 (1 atm) was passed through the 
solution for 10 minutes. The solution was then stirred for 4-6 h. Then the reaction mixture was 
filtered through a celite-filled sintered glass funnel and washed with 50 mL of MeOH. The MeOH 
was removed under reduced pressure to give 187 mg of a colorless oily residue. The latter and 123 
mg (1.22 mmol) of NEt3 were dissolved in 20 mL of dry CH2Cl2. 0.373 mL (335 mg, 1.22 mmol) of 
palmitoyl chloride were added and the resulting mixture was stirred for 3 h. The organic solvent 
was removed under reduced pressure and the crude product was purified over a silica gel column 
(MeOH-CH2Cl2 5%) to give 248 mg of a white solid (26% yield over three steps). 
Rf=0.53 (MeOH-CH2Cl2 5%) 
1H NMR (500 MHz, CDCl3) δ 7.40 – 7.27 (m, 1H), 4.18 – 4.02 (m, 4H), 4.03 – 3.86 (m, 1H), 3.78 – 
3.18 (m, 6H), 2.26 – 2.11 (m, 4H), 1.60 (s, 4H), 1.44 (s, 9H), 1.25 (s, 48H), 0.99 – 0.71 (m, 6H). 
13C NMR (126 MHz, CDCl3) δ 175.7, 175.6, 174.4, 174.2, 156.1, 79.6, 66.1, 64.9, 53.4, 50.7, 40. 9, 
40.3, 40.0, 36.7, 36.6, 31.9, 29.71, 29.67, 29.6, 29.39, 29.37, 29.3, 28.4, 25.8, 25.7, 22.7, 14.1, 
10.1. 
31P NMR (121 MHz, CDCl3) δ 15.2. 
HRMS (ESI+) C42H86N4O7P m/z calcd [M+H]+789.6228 obs. 789.6206 
FTIR (cm-1): 3309, 2917, 2850, 1689, 1636, 1534, 1466, 1366, 1239, 1172, 1034, 1000, 723, 690 
Mp=98-102°C
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1.4 rac-2,3-dipalmitamidopropyl (2-(trimethylammonio)ethyl) phosphate (Pad-Pad-PC, 5) 
To the protected phosporamidate Pad-Pad-PEBoc (7) (88 mg, 
0.127 mmol) were added 5 mL of 1 M solution of HCl in dioxane 
until 7 was completely dissolved. The solution was stirred for 1.5 
h. The product precipitated out of this solution and the solvent was removed under reduced 
pressure providing a yellow solid. It was redissolved in 15 mL of MeOH, heated up to 40°C and 
treated with an excess of of dimethylsulfate (120 µL, 160 mg, 1.27 mmol). After stirring for 30 min, 
K2CO3 (176 mg, 1.27 mmol) in 2 mL of H2O was added in 15 s using a syringe. The solution was 
left stirring for 30 min, then the solvents were removed under a flow of nitrogen. The crude mixture 
was purified using a SEPHADEX LH-20 column (CH2Cl2-CH3-OH-H2O 65:25:4) giving 39 mg of a 
white powder (53µmol, 42% over two steps). 
Rf=0.36 (CH2Cl2-CH3-OH-H2O 65:25:4) 
1H NMR (400 MHz, CDCl3) δ 8.02 – 7.75 (m, 2H), 4.39 (s, 2H), 4.11 – 3.67 (m, 7H), 3.59 – 3.44 (m, 
2H), 3.41 (s, 9H), 2.20 (dt, J = 8.3, 6.8 Hz, 4H), 1.60 (d, J = 5.9 Hz, 4H), 1.31 (s, 47H), 0.92 (t, J = 
6.8 Hz, 6H). 
13C NMR (126 MHz, CDCl3) δ 175.4, 174.4, 66.4, 64.3, 59.5, 54.5, 51.7, 51.3, 40.9, 36.7, 36.6, 
31.9, 29.8, 29.70, 29.66, 29.55, 29.46, 29.43, 29.39, 25.9, 25.84 22.7, 14.1. 
31P NMR (162 MHz, CDCl3) δ 0.7. 
HRMS (ESI+)m/z calcd [M+H]+ 732.6014 obs. 732.6029 
FTIR (cm-1): 3287, 2917, 2850, 1634, 1544, 1468, 1232, 1055, 969, 925, 830, 722 
Mp=195-198°C 
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2. Metabolism of Pad-PC-Pad by Phospholipase A2 
An experiment was carried out according to the procedure of Sunamoto et al.9 A buffer solution 
containing 10 mM Tris.HCl, 10 mM CaCl2 and 154 mM NaCl was prepared. To 50 mL of this 
solution, 5 mg of Phospholipase A2 (PLA2, Bee venom, 600-2400 U/mg) was added. 
Dipalmitoylphosphocholine (DPPC) (5.0 mg) was dissolved in diethyl ether-ethanol (3 mL, 80:20 by 
vol) and the solution was divided into 20 mL glass vials in two equal portions. To one vial, buffer 
solution was added (200 µL, TLC spot 1, Figure S9, below). To the other, PLA2-containing buffer 
solution was added (200 µL, spot 2,). Pad-PC-Pad (1) (5.0 mg) was dissolved in diethyl ether-
ethanol (3 mL, 80:20 by vol), divided into two vials and diluted with the buffer solution (spot 4) and 
PLA2-containing buffer solution (spot 5) in the same manner. 
The solutions were stirred for 18 hours. At given time intervals, 3 µL of solution was withdrawn and 
submitted to TLC analysis developed by dichloromethane:methanol:water (65:25:4 by vol). Plates 
(Figure S9) were visualised using potassium permanganate solution. 
 
Figure S1 | Metabolism of phospholipase A by Pad-PC-Pad. TLC spots, 1-6: 1, DPPC and 
buffer; 2, DPPC and PLA2-containing buffer; 3, co-spot 1 and 2; 4, Pad-PC-Pad and buffer; 5, Pad-
PC-Pad and PLA2-containing buffer; 6, co-spot 4 and 5. 
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3. DSC studies of Pad-PC-Pad 
 
Figure S2 | DSC of Pad-PC-Pad. It is interesting to note that while the confocal image of GUVs 
shows a polyhedral population of vesicles with ≈30% of a liquid phase surrounded by a solid 
phase, DSC data show (i) a sharp transition from gel to fluid phase at 35 °C, and (ii) the dH 
corresponds to clear transitions between a solid phase and a liquid phase. One explanation for 
such a discrepancy could be the different packing density in GUVs/monolayer as compared to 
LUVs. From this figure, one would expect coexisting gel and fluid domains between ~25-40 °C. 
This could explain the discrepancy between the DSC melting behavior and confocal images and 
why coexisting domains were observed in GUVs. 
 
4. Calculation of encapsulation efficiency of a typical non-spherical phospholipid vesicle 
We assumed that the vesicle forms a lenticular shape. A typical vesicle with maximum diameter of 
114 nm and maximum height of 80 nm was selected (Figure S1). It was presumed that the vesicle 
was symmetrical and that the discontinuity round the diameter was circular when viewed from the 
top. The total surface area of the vesicle was calculated as 3 x 104 nm2 and volume was calculated 
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as 4.75 x 105 nm3. For a spherical vesicle of the same surface area (i.e. lipid content), the volume 
was calculated as 4.90 x 105 nm3. 
 
Figure S3: Pad-PC-Pad LUVET100 Cryo-TEM image. The lenticular shape has a maximum 
diameter at 114 nm across the discontinuity and 80 nm at the maximum height. The vesicle is 
approximated to be symmetrical above and below the discontinuity. 
 
5. Measurement of vesicle-encapsulated volume 
A phosphate assay was used according to Sauder, R. et al., Meth Mol Biol 2011, 683: 129-155: 
The phospholipid content is measured as phosphate content after oxidation of the phospholipids 
with perchloric acid. The liberated inorganic phosphate ion reacts with ammonium molybdate to 
phospho-molybdic acid which is measured spectrophotometrically. The sensitivity of the detection 
is increased in the presence of cationic malachite green. Dried KH2PO4 at 5-20 nmol is used for 
calibration. The assay is thus incompatible with phosphate based buffers. When using 
higher phosphate concentrations and readings later than 20 min. after reagent addition, 
stabilization of the colored complex with surfactants such as Tween20 is required . 
1. Wear protection glasses, gloves and lab coat. 
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2. Coloring reagent: 1.05 g of ammonium molybdate ((NH4)6MoO24·4H2O) is dissolved in 15 mL of 
6 N HCl; this is added to 0.12 g of Malachite Green previously dissolved in 85 mL of H2O. After 30 
min of stirring, the reagent is filtered (filter paper #1,Whatman; Maidstone, UK). The reagent is 
stored at room temperature and is freshly filtered prior to use (0.2·µm PTFE syringe filter, 
Whatman; Maidstone, UK). The reagent is stable for 6 weeks. Thereafter, the assay leads to 
increased OD values and non-linearity in the standard curve. 
3. An aliquot of ~150 nmol of phospholipids (e.g. 30 µL of a 5 mM POPC suspension) is placed into 
a 8x60 mm borosilicate glass tube (art. 26.013.201, Glas Keller; Basel; Switzerland) 
4. 100 µL of perchloric acid (70%) are added. 
5. Behind a protection shield and in a fumehood, the vial is hold with a forceps (tube opening 
opposed to the body) and is gently boiled with a bunsen burner for approximately 3-4 min, so that 
the solution first turns yellow and, after a short burst of white smoke, gets clear again leaving ~1/2 
of the original volume. After cooling, the solution is completed with water to 1.0 mL. 
6.1. A tenth of it (100 µL; triplicate) is placed into a disposable plastic cuvette (1 cm path length), 
and 900 µL of the freshly filtered coloring reagent is added and immediately mixed. 
6.2 For the blank, 100 µL of water are placed in a cuvette and 900 µL of the coloring reagent are 
added and mixed. 
6.3. For the standard curve, 5, 10, 15 ad 20 µL of a 1 mM KH2PO4 solution are placed into a 
cuvette, followed by completion with water to 100 µL and addition of 900 µL of the coloring reagent. 
7. A time-scan (light absorbance at 660 nm) of the most concentrated standard is recorded (i.e. 20 
nmol of KH2PO4) , where the OD signal will increase after ~10 min to a ΔOD of ~ 0.9 (with regard 
to the blank) and will stay stable for ~30 min. 
8. The interval between addition of the coloring reagent and achievement of stable signal (i.e. ~10 
min) is kept equal for all samples. 
The following results were obtained: 
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constants    
vesicle diameter 1.14E-07 m  
bilayer thickness 3.70E-09 m  
Head Group area Pad-PC-Pad 5.60E-19 m^2  
    
experimental values    
[PO4], assay 4.36E-06 M ± 9E-8 
entrapped CF, min 7.60E-05 frxnl volume 
entrapped CF, max 1.04E-04 frxnl volume 
    
    
1. [PO4] assay : predicted entrapped vol. for spherical vesicles 
    
n° molecules in outer sphere 7.29E+04   
n° molecules in inner sphere 6.37E+04   
total molecules in spherical vesicle 1.37E+05   
moles of lipid in 1 vesicle 2.27E-19 M  
    
predicted n° spherical vesicles 1.92E+13 in 1 L  
    
encapsulated vol of 1 vesicle 5.07E-21 m^3  
 5.07E-18 L  
total expected encapsulated 
volume for spherical vesicles 9.75E-05 frxnl volume 
within the range of entrapped 
CF (calc'd experimentally, 
results above) 
    
    
2. CF assay : predicted [PO4] for spherical vesicles  
    
From entrapped CF, max:    
Number of vesicles 2.05E+13 in 1 L  
total expected [PO4] for spherical 
vesicles (CF max): 4.65E-06 M  
    
From entrapped CF, min:    
Number of vesicles 1.50E+13 in 1 L  
total expected [PO4] for spherical 
vesicles (CF min): 3.40E-06 M 
within the range of [PO4] assay 
(calc'd experimentally, results 
above) 
 
6. Cytotoxicity assay  
Cytotoxicity of the liposomes was investigated by the in vitro MTS assay (according to ISO 10993-
5) and determination of cell number. L929 cells (ATCC CCL-1) and MG63 cells (ATCC CRL-1427) 
were seeded at a density of 1 x 104 cells/cm2 in a 96 well plate format for 24 hours in standard cell 
culture medium. Egg-PC and Pad-PC-Pad liposomes were diluted from a 1000 µg/mL stock 
© 2012 Macmillan Publishers Limited.  All rights reserved. 
 
2.3 Proof of principle: Mechano-sensitive nano-containers for targeted drug
delivery to constricted vessels in the heart 63
 14 
(isotonic 10 mM HEPES, 10 mM NaCl, pH 7.4 buffer) in cell culture medium to concentrations of 
200 µg/mL, 100 µg/mL, 20 µg/mL and 10 µg/mL. For all liposome dilutions, the HEPES/NaCl buffer 
was adjusted to 20%. L929 cells were cultured for 24 or 48 hours with the liposome dilutions and 
cytotoxicity was assessed in triplicate by the MTS assay (Promega), following manufacturersʼ 
instructions (Figure S11a,b, below). 
To additionally determine the cell number, crystal violet staining was performed on the MTS test 
plate containing the cells (Figure S11c,d). For this, the cells were washed with PBS, fixed for 10 
minutes in isopropanol, permeabilised with 0,05% Tween and stained with 0.1% crystal violet for 15 
minutes. After washing with de-ionised water, the crystal violet was dissolved with 33% acetic acid 
and the supernatant was measured at 600 nm to quantify cell numbers10. 
 
Figure S4 | Cytotoxicity assay for Pad-PC-Pad and Egg-PC liposomes at 24 hours (light 
gray) and 48 hours (dark gray). MTS assay of Pad-PC-Pad (a) and Egg-PC (b). MTS conversion 
normalised for cell number of Pad-PC-Pad (c) and Egg-PC (d) vesicles. None of the vesicle 
dilutions show a cytotoxic effect on L929 cells after 24 and 48 hours: MTS conversion and cell 
numbers were not reduced compared to the medium control, in the contrary, they where slightly 
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increased. A 24 hours cytotoxicity assay for MG-63 cells revealed the same results (data not 
shown). 
 
7. Complement activation test 
C3 C4 Sample 
g/l g/l 
Without incubation 1.05 0.198 
Incubated  with blank (NaCl 0.9%) 0.993 0.226 
Incubated  with 4.5 µM Pad-PC-Pad 0.945 0.23 
Incubated  with 15 µM Pad-PC-Pad 0.99 0.23 
Incubated  with 45 µM Pad-PC-Pad 0.988 0.229 
Incubated  with 0.45 µM Pad-PC-Pad 0.981 0.225 
 
Table S1 | C3 and C4 complement pathway activation for naked Pad-PC-Pad LUVET100 
measured in the supernatants by nephelometry (Beckman Image analyser). C3 measurement 
investigates the common complement pathway activation. C4 measurement investigates the 
classical complement pathway activation. Results are mean of duplicates. There are no significant 
differences between the samples and the results do not suggest complement activation.  
 
Naked Pad-PC-Pad LUVET100 with NaCl (0.9%, pH 7.4) as both the internal and external buffer, 
were prepared in the usual manner. Human blood plasma(1 mL) was mixed with a 50 µL of the 
Pad-PC-Pad liposome suspension diluted to the appropriate concentration and incubated at 37°C 
for 45 min to allow complement activation. Plasma was then centrifuged at 2500g for 10 min.  
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8. Vesicle age 
 
Figure S5 | Age of vesicles. After the extrusion, vesicles were stored at room temperature for 1-3 
days. After this, they were subjected to vortex shaking for up to 60 s at 20 °C. No effect of 
prolonged storage was visible in this experiment. 
 
9. Mechanosensitivity 
In contrast to Pad-PC-Pad (1), EggPC (4) vesicles leak both at rest and being mechanically 
stressed. One possible explanation for this leaking could be the critical temperature which was 
found to be 21-26 °C for an EggPC bilayer membrane. In this temperature window a 25% lower 
shear force was sufficient to induce membrane leakage3. However, Figure 3c shows that under the 
conditions used in the present work, the carboxyfluorescein release from EggPC (4) upon shearing 
is independent of the applied temperature in the range between 4-45 °C. Earlier studies also 
concluded that the release from vesicles made from unsaturated phospholipids, such as EggPC, is 
less temperature dependent than from vesicles made from saturated ones22. We find the opposite 
for Pad-PC-Pad (1) vesicles: below their Tm of 35 °C they are equally labile to mechanical stress as 
EggPC vesicles. However, we observe that EggPC (4) vesicles are unstable resting at room 
temperature, whereas Pad-PC-Pad (1) vesicles are stable. One explanation for the intrinsic stability 
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could be the relative Tm of the two lipids. EggPC has a Tm of -2 °C so exists in the liquid phase at 
room temperature. It is easier to transport a molecule through this liquid phase than a solid phase, 
such as the Pad-PC-Pad (1) bilayer. All experiments at room temperature are therefore dealing 
with different phases so the release mechanism will be different. 
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10. Vesicle aggregation 
Unlabeled LUVET100 were formulated from pure Pad-PC-Pad (1) and subjected to vortex shaking. 
For each time point a TEM micrograph was taken. Figure S2 shows the aggregation of vesicles 
over time. 
t = 20 s
t = 10 st = 5 st = 0 s
t = 60 st = 30 s
200 µm
 
Figure S6| Transition electron micrographs of LUVs formulated from Pad-PC-Pad. The 
aggregation of vesicles after shaking of the vesicle suspension on a vortex shaker. 
 
11. Additional monolayer studies of Pad-PC-Pad reveal a two-phase coexistence 
A likely explanation for the shear-sensitive instability of Pad-PC-Pad vesicles compared to the 
natural phospholipids 2 and 3 is the propensity for phase separation in the membrane leading to an 
increased isothermal lateral compressibility2. Indeed, Pad-PC-Pad in monolayer experiments had a 
region of >0.1 mN/m compressibility at 20 mN/m surface pressure that was lacking for the natural 
phospholipids (Figure S5). The crystalline regions form ramified islands, with branches protruding 
from the starburst structure. The extent of crystalline island coverage is around 40%. The branch 
width of the primary starburst structure is constant and corresponds to about 2.2 µm or 2,700 
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molecules (52 Å2 per head group). The branches do not appear to taper at the periphery. The 
secondary branches have a width of up to 1.3 µm. The island distribution is heterogeneous and at 
regions of higher island density the termini of branches fuse. 
The ramified islands show a characteristic morphology, independent of the imaging technique used 
(BAM and fluorescence microscopy, Figure 4b,c). This indicates that the presence of the 
fluorescence marker does not significantly influence the island formation. The images were taken 
under similar experimental settings in different institutes. The captured stages of island growth are 
not identical. 
The nature of such islanding should be studied in more detail to reveal the underlying processes as 
done for epitaxial metal, semiconductor and organic materials, see e.g., Müllerʼs5 review. A starting 
point could be the observation that the smaller islands are rather compact, whereas the larger ones 
are ramified. Therefore, the island perimeter versus island size might give rise to a similar behavior 
as observed for Cu/Ni(100)6. 
 
Figure S7| Additional monolayer studies of Pad-PC-Pad. The isothermal lateral compressibility 
of the lipids extracted from the pressure-area isotherms. The arrow points at a high compressibility 
found for Pad-PC-Pad that is absent at such high pressures for the other lipids tested. Negative 
values (decreasing slope of the isotherm) were suppressed. 
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12. Influence of shearing during preparation and performing the experiments 
 
Figure S8 |Dependence of fractional release on shear stress.  Increased severity of stenosis 
leads to an increase in observed fractional release of liposome contents. Shear stresses were 
calculated as ~2 Pa (common) and ~40 Pa (constricted artery) using the formula7: τ = 4µQ/π r3, 
where µ is viscosity of water at 35 °C (7.1 x 10-4 Pa·s)8, Q is flow rate (common, 8.3 x 10-6 m3/s; 
constricted 5.8 x 10-6 m3/s), r is radius (common, 1.25 mm; constricted, 0.5 mm). Results are from 
one experiment and error bars represent the standard deviation of the fluorescence release in 6 
200 µL samples read on a 96 well plate reader. 
 
13. Rheology experiments with Pad-PC-Pad: Shear-stress induced release 
Release studies with the in vitro setup (above) give a reasonable approximation of the physical 
forces in the body. Of course, the system represents an in vitro model of the physical forces in the 
heart, and all release observed cannot be attributed entirely to the changes in shear stress within 
the system. Effects such as reflow and turbulence are also present. We investigated the leakage of 
carboxyfluorescein from a sample of vesicles in human serum albumin (HSA, 40 g/L) and HEPES 
buffer after applying a pre-defined shear stress. The use of HSA in the external media also allows 
us to observe the effect of proteins on liposome stability. At 34 °C we found an increase in 
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fluorescence release by raising the shear stress. The presence of HSA led to an apparent 
stabilisation of the vesicles to shear stress induced release. Vesicles in HEPES buffer have been 
shown to release all their cargo on heating to 34 °C whereas vesicles in HSA-containing HEPES 
external buffer only release 80 %.A Bohlin CS 120 Rheometer with Casson cup and bob sample 
holder was used for the following experiments. Briefly, the sample was equilibrated for 2 minutes to 
34 or 37 °C in the sample holder then a shear stress of 0.5–5 Pa was applied to a sample of 
vesicles in HEPES buffer with 40 g/L HSA for 1 minutes. The release was then measured by 
fluorescence spectroscopy using a 96-well plate and 200 µL samples incubated with or without 
Triton X-100 (4 µL) for half an hour at 25 °C. Each bar in Figure S10 is an average of six samples. 
 
 
 
Figure S9 | Shear-stress induced release from Pad-PC-Pad vesicles. Data is at 37 °C (red) 
and 34 °C (blue). With increased shear stress there is a clear increase in release from the vesicles 
at 37 °C, just above their Tm. At 34 °C the vesicles are just below their Tm and no such correlation 
is observed. At 34 °C, the control at 0 Pa releases more than the vesicles subjected to shear-
stress. We postulate that this is due to an effect of the HSA, which shows slightly milky solutions 
after heating which could lead to difraction in the spectrofluorometer. 
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When Triton X-100 is added to HSA at these concentrations we observe a 50% decrease in 
expected fluorescence intensity. The raw data in these samples are therefore multiplied by two to 
take this phenomenon into account. The results are shown above. 
 
14. Release after prolonged recirculation 
 
Figure S10 | Release of the Egg-PC with 0.6 mol% Brij S10. Bars indicate the standard 
deviation from the three experiments. The x-axis shows number of passes through the model 
artery. Flow rate is twice as fast in the common model. Therefore, in 20 minutes the vesicles pass 
an average to 80 times though this model compared to 40 times for the constricted model. It can be 
seen that, even though circulation for 20 minutes leads to double the number of arterial passes, the 
release in the common model is still smaller than that of the constricted model after 40 passes. 
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Figure S11 |Fluorescent release from Egg-PC liposomes with a defined percentage of Pad-
PC-Pad concentration. 100% implies 100% Pad-PC-Pad liposomes. Results from all experiments 
are presented as fluorescence release as a function of number of passes through the arterial 
model (Figure 3). The data are not normalised to zero at the zero passes so that the inherent 
“leakiness” of the vesicles during the preparation of the sample is also observable. It is clear that 
increasing the concentration of Pad-PC-Pad leads to an increase in overall release, but not to a 
targeted release at the stenosis over long time scales.  
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3 Conclusions and Outlook
A combination of µCT imaging techniques was most effective for build-
ing a full picture of the morphology and tissue composition of critically
constricted human coronary arteries.
Advanced laboratory µCT (Phoenix|x-ray, GE Sensing & Inspection
Technologies GmbH, Wunstorf, Germany) was sufficient for segment-
ing and extracting the lumen mesh from datasets of decalcified human
coronary arteries and PMMA plastic models of a healthy and diseased
human coronary artery. Laboratory µCT confirmed that the morphol-
ogy of these PMMA models was in agreement with measurements per-
formed on a human coronary artery, with the diseased PMMA model
artery exhibiting a critical constriction (>80% by cross-sectional area).
Both PMMA models were incorporated into an in vitro flow system
with extra-corporeal circulation pump to simulate the heart. This
model was used in experiments to assess the suitability of shear-stress
sensitive liposome formulations as drug delivery vectors.
Absorption-SRµCT data gave a higher density and spatial resolution
than laboratory µCT, and was also suitable for the extraction of a lu-
men mesh from decalcified human coronary afteries. Streak artifacts
caused by residual plaque did not interfere with the lumen segmen-
tation procedures. A mesh extracted from absorption-SRµCT data
of a critically constricted human coronary artery was used for flow
simulations, which calculated a maximum shear stress of 18 Pa, an
order of magnitude higher than shear stresses observed in the normal
vascular system. Such simulations are critical for determining the re-
quired shear stress “break-point” of mechano-sensitive nano-containers
for targeted release at the site of critical constricted human coronary
arteries.
Phase-SRµCT gives high contrast images from which different tis-
sues types can be identified by comparison with histology. However,
phase-SRµCT datasets are unsuitable for lumen segmentation and ex-
76 3 Conclusions and Outlook
traction, due to artifacts arising from air bubbles encapsulated in
the paraffin embedding material. This might be overcome by using
formaldehyde as a storage medium in place of paraffin. Coupled with
histology reference slices, phase-SRµCT is an indispensable tool for
identifying the 3D morphology of tissue composition in decalcified hu-
man coronary arteries.
Lenticular Pad-PC-Pad liposomes contain preferential breaking points
along their equators that make them sensitive to increased shear-
stresses. In vitro experiments, using the above-described PMMA
model of healthy or critically constricted arteries, showed that Pad-
PC-Pad vesicles preferentially release encapsulated contents in areas of
high shear stress such as those found in the critically constricted arter-
ies of heart attack sufferers. The difference between release of the fluo-
rophore carboxyfluorescein from Pad-PC-Pad vesicles passed through
either a healthy or critically constricted PMMA model was 25% af-
ter one pass only. This was an order of magnitude larger than the
best identified natural liposome formulation, EggPC with 0.6 mol%
Brij S10, which showed 14% difference in release after 40 passes. This
finding could lead to significant innovations in targeted drug delivery
using solely physics-based triggers.
The project is still far from seeing a product on the market, and there
are several important areas of investigation that must first be ad-
dressed. To achieve the necessary level of in vivo specificity, the min-
imum required corresponding percentage increase in release of encap-
sulated contents from mechano-sensitive nano-containers at sites of in-
creased shear stress (i.e. critically constricted arteries) must be defined
on a case by case basis, for specific drugs and applications. To achieve
this, one must quantify the dose-response curves of the free drugs (in
consultation with medical doctors) and the rate at which they per-
meate through the vesicle membrane bilayer. Additionally, a library
of meshes of critically constricted human coronary arteries should be
constructed, using the protocol presented in Chapter 2.1. The cal-
culated shear stresses would quantify the required “break points” for
optimal drug delivery from mechano-sensitive nano-containers. Then,
by building on these findings, an optimal vesicle formulation should be
identified. Using for example microfluidic devices capable of exerting
a defined shear-stress on vesicles, one could subsequently measure the
77
“break points” of potential vesicle formulations to within 0.1 Pa. Fi-
nally, in vivo toxicology and dose-response experiments using suitable
animal models are required before progressing to human trials.
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